{
    "url": "https://www.gilead.com/science/pipeline",
    "statusCode": 200,
    "browserHtml": "<!DOCTYPE html><!--[if lt IE 7]>      <html class=\"no-js lt-ie9 lt-ie8 lt-ie7\"> <![endif]--><!--[if IE 7]>         <html class=\"no-js lt-ie9 lt-ie8\"> <![endif]--><!--[if IE 8]>         <html class=\"no-js lt-ie9\"> <![endif]--><!--[if gt IE 8]><!--><html class=\"js no-applicationcache audio audio-ogg audio-mp3 audio-opus audio-wav audio-m4a canvas canvastext geolocation hashchange history inputformnovalidate input-formnovalidate inputtypes-search inputtypes-tel inputtypes-url inputtypes-email no-inputtypes-datetime inputtypes-date inputtypes-month inputtypes-week inputtypes-time inputtypes-datetime-local inputtypes-number inputtypes-range inputtypes-color postmessage postmessage-structuredclones svg svgclippaths inlinesvg smil video no-video-ogg video-h264 no-video-h265 video-webm video-vp9 no-video-hls no-video-av1 webgl websockets cssanimations backgroundsize borderimage borderradius boxshadow csscolumns csscolumns-width csscolumns-span csscolumns-fill csscolumns-gap csscolumns-rule csscolumns-rulecolor csscolumns-rulestyle csscolumns-rulewidth csscolumns-breakbefore csscolumns-breakafter csscolumns-breakinside flexbox fontface generatedcontent cssgradients hsla multiplebgs opacity cssreflections rgba textshadow csstransforms supports csstransforms3d csstransitions localstorage sessionstorage no-websqldatabase webworkers indexeddb no-audioautoplay indexeddb-deletedatabase\" lang=\"en\"><!--<![endif]--><head>\n<link href=\"/-/media/gileadcorpredesign/experience-accelerator/gilead-bootstrap-5/gilead-bootstrap-5/styles/optimized-min.css?t=20240911T183235Z\" rel=\"stylesheet\"><link href=\"/-/media/base-themes/core-libraries/styles/optimized-min.css?t=20250522T071941Z\" rel=\"stylesheet\"><link href=\"/-/media/base-themes/gilead-main-theme/styles/optimized-min.css?t=20240911T155622Z\" rel=\"stylesheet\"><link href=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/styles/optimized-min.css?t=20251103T064019Z\" rel=\"stylesheet\">\n\n    \n<meta name=\"VIcurrentDateTime\" content=\"638981385473543864\">\n<meta name=\"VirtualFolder\" content=\"/\">\n<script type=\"text/javascript\" async=\"\" src=\"https://www.googletagmanager.com/gtag/destination?id=DC-3471255&amp;cx=c&amp;gtm=4e5b50\"></script><script type=\"text/javascript\" async=\"\" src=\"https://www.googletagmanager.com/gtag/js?id=G-P4V73QC2RV&amp;cx=c&amp;gtm=4e5b50\"></script><script type=\"text/javascript\" id=\"www-widgetapi-script\" src=\"https://www.youtube.com/s/player/65578ad1/www-widgetapi.vflset/www-widgetapi.js\" async=\"\"></script><script src=\"https://player.vimeo.com/api/player.js\"></script><script src=\"https://www.youtube.com/player_api\"></script><script async=\"\" src=\"https://www.googletagmanager.com/gtm.js?id=GTM-TZLH92\"></script><script type=\"text/javascript\" src=\"/layouts/system/VisitorIdentification.js\"></script>\n\n    \n\n\n\n<!-- Google Tag Manager --> \n<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-TZLH92');</script>\n<!-- End Google Tag Manager -->\n\n    <title>Virology, Inflammation, &amp; Oncology Pipeline | Gilead</title>\n\n\n\n\n    <link href=\"/-/media/gileadcorpredesign/images/favicon_180.png\" rel=\"shortcut icon\">\n\n\n\n\n<meta name=\"description\" content=\"Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, &amp; inflammation. Learn about our pipeline. \"><meta name=\"keywords\" content=\"pipeline,  Gilead pipeline  \">      <meta property=\"og:title\" content=\"Virology, Inflammation, &amp; Oncology Pipeline | Gilead\">\n      <meta property=\"og:description\" content=\"Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, &amp; inflammation. Learn about our pipeline. \">\n      <meta property=\"og:image\" content=\"https://gilead.stylelabs.cloud/api/public/content/3d4fc9966e5f412bb3be0976e57fb78f?v=04ff0ea2\">\n      <meta property=\"og:type\" content=\"website\">\n      <meta property=\"og:site_name\" content=\"Gilead\">\n      <meta property=\"og:url\" content=\"https://www.gilead.com/science/pipeline\">\n      <meta property=\"twitter:title\" content=\"Virology, Inflammation, &amp; Oncology Pipeline | Gilead\">\n      <meta property=\"twitter:description\" content=\"Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, &amp; inflammation. Learn about our pipeline. \">\n      <meta property=\"twitter:image\" content=\"https://gilead.stylelabs.cloud/api/public/content/3d4fc9966e5f412bb3be0976e57fb78f?v=04ff0ea2\">\n      <meta property=\"twitter:card\" content=\"summary\">\n\n\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n  <link rel=\"canonical\" href=\"https://www.gilead.com/science/pipeline\">\n  <link rel=\"alternate\" hreflang=\"en\" href=\"https://www.gilead.com/science/pipeline\">\n\n  <meta name=\"robots\" content=\"index,follow\">\n\n\n<!-- Proxima nova font for Gcom and other Affiliates -->\n<link href=\"https://use.typekit.net/iad1gkg.css\" rel=\"stylesheet\">\n<script src=\"https://cdn.cookielaw.org/scripttemplates/202508.1.0/otBannerSdk.js\" async=\"\" type=\"text/javascript\"></script><style id=\"onetrust-style\">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-button-order-0{order:0}#onetrust-banner-sdk .ot-button-order-1{order:1}#onetrust-banner-sdk .ot-button-order-2{order:2}#onetrust-banner-sdk #onetrust-close-btn-container svg{height:10px;width:10px;pointer-events:none}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .pc-logo svg,#onetrust-pc-sdk .ot-pc-logo svg{height:60px;width:180px}#onetrust-pc-sdk #close-pc-btn-handler>svg{margin:auto;display:block;height:12px;width:12px}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo svg,#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.8em;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px}#onetrust-banner-sdk .ot-optout-signal svg.ot-source-sprite,#onetrust-pc-sdk .ot-optout-signal svg.ot-source-sprite{position:relative;bottom:-3px}#onetrust-banner-sdk .ot-optout-signal svg:not(.ot-source-sprite),#onetrust-pc-sdk .ot-optout-signal svg:not(.ot-source-sprite){transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg:not(.ot-source-sprite) path,#onetrust-pc-sdk .ot-optout-signal svg:not(.ot-source-sprite) path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk #onetrust-sprite-svg{display:none}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk img,#onetrust-pc-sdk img,#ot-sdk-cookie-policy img,#ot-sync-ntfy img{overflow:hidden !important}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:\"\";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:\"\";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-group-container{position:relative}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px;margin-right:5px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (max-width: 550px){#onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{margin-right:0}#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{margin-right:0}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{width:auto}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container{display:inline-flex;flex-wrap:wrap}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler{float:none}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(1){margin-right:auto !important}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group.ot-button-order-container{width:auto}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:80%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}\n        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFFFFF;}\n            #onetrust-consent-sdk #onetrust-policy-title,\n                    #onetrust-consent-sdk #onetrust-policy-text,\n                    #onetrust-consent-sdk .ot-b-addl-desc,\n                    #onetrust-consent-sdk .ot-dpd-desc,\n                    #onetrust-consent-sdk .ot-dpd-title,\n                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),\n                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),\n                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,\n                    #onetrust-banner-sdk .ot-cat-header,\n                    #onetrust-banner-sdk .ot-optout-signal\n                    {\n                        color: #3b3b3b;\n                    }\n            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {\n                    background-color: #E9E9E9;}\n             #onetrust-consent-sdk #onetrust-banner-sdk a[href],\n                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,\n                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn\n                        {\n                            color: #4D5E81;\n                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,\n                         #onetrust-banner-sdk #onetrust-reject-all-handler {\n                            background-color: #c50f3c;border-color: #c50f3c;\n                color: #FFFFFF;\n            }\n            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,\n            #onetrust-consent-sdk #onetrust-banner-sdk:focus {\n               outline-color: #000000;\n               outline-width: 1px;\n            }\n            #onetrust-consent-sdk #onetrust-pc-btn-handler,\n            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {\n                color: #c50f3c; border-color: #c50f3c;\n                background-color:\n                #FFFFFF;\n            }#onetrust-banner-sdk #onetrust-policy-text a.ot-cookie-policy-link,\n                         #onetrust-banner-sdk #onetrust-policy-text a.ot-imprint-link {\n                    margin-left: 5px;\n                }#onetrust-banner-sdk #onetrust-button-group {\n        display: flex !important ;\n\t\n       }\n@media screen and (max-width: 440px) {\n#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{\n    flex-direction: column;\n}\n}\n#ot-sdk-btn-floating.ot-floating-button {\n    width: 48px;\n    height: 21px;\n    @media(max-width: 768px) {\n        width: 38px;\n        height: 18px;\n    }\n}#onetrust-pc-sdk{position:fixed;width:730px;max-width:730px;height:610px;left:0;right:0;top:0;bottom:0;margin:auto;font-size:16px;z-index:2147483647;border-radius:2px;background-color:#fff;box-shadow:0 2px 4px 0 rgba(0,0,0,0),0 7px 14px 0 rgba(50,50,93,.1)}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before{box-sizing:content-box}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 185px)}#onetrust-pc-sdk li{list-style:none}#onetrust-pc-sdk ul,#onetrust-pc-sdk li{margin:0}#onetrust-pc-sdk ul li div:focus{margin:0px 2px !important}#onetrust-pc-sdk ul:focus-within{padding-top:2px !important}#onetrust-pc-sdk .ot-desc-cntr:focus{outline-offset:-1px !important}#onetrust-pc-sdk a{text-decoration:underline}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk .ot-grps-cntr *::-webkit-scrollbar,#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-grps-cntr *::-webkit-scrollbar-thumb,#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-pc-sdk .ot-grps-cntr *,#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-pc-sdk .ot-pc-header{height:auto;padding:10px;display:block;width:calc(100% - 20px);min-height:52px;border-bottom:1px solid #d8d8d8;position:relative}#onetrust-pc-sdk .ot-pc-logo{vertical-align:middle;width:180px}#onetrust-pc-sdk .ot-pc-logo.ot-pc-logo{height:40px}#onetrust-pc-sdk .ot-title-cntr{position:relative;display:inline-block;vertical-align:middle;width:calc(100% - 190px);padding-left:10px}#onetrust-pc-sdk .ot-optout-signal{margin:.625rem .625rem .625rem 1.75rem}#onetrust-pc-sdk .ot-always-active{font-size:.813em;line-height:1.5;font-weight:700;color:#3860be}#onetrust-pc-sdk .ot-close-cntr{float:right;position:absolute;right:-9px;top:50%;transform:translateY(-50%)}#onetrust-pc-sdk #ot-pc-content{position:relative;overflow-y:auto;overflow-x:hidden}#onetrust-pc-sdk #ot-pc-content .ot-sdk-container{margin-left:0}#onetrust-pc-sdk .ot-grps-cntr,#onetrust-pc-sdk .ot-grps-cntr>*{height:100%;overflow-y:auto}#onetrust-pc-sdk .category-menu-switch-handler{cursor:pointer;border-left:10px solid rgba(0,0,0,0);background-color:#f4f4f4;border-bottom:1px solid #d7d7d7;padding-top:12px;padding-right:5px;padding-bottom:12px;padding-left:12px;overflow:hidden}#onetrust-pc-sdk .category-menu-switch-handler h3{float:left;text-align:left;margin:0;color:dimgray;line-height:1.4;font-size:.875em;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-active-menu{border-left:10px solid #68b631;background-color:#fff;border-bottom:none;position:relative}#onetrust-pc-sdk .ot-active-menu h3{color:#263238;font-weight:bold}#onetrust-pc-sdk .ot-desc-cntr{word-break:break-word;word-wrap:break-word;padding-top:20px;padding-right:16px;padding-bottom:15px}#onetrust-pc-sdk .ot-grp-desc{word-break:break-word;word-wrap:break-word;text-align:left;font-size:.813em;line-height:1.5;margin:0}#onetrust-pc-sdk .ot-grp-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc a{color:#3860be;cursor:pointer;font-size:1em}#onetrust-pc-sdk #ot-pc-desc a.privacy-notice-link,#onetrust-pc-sdk #ot-pc-desc a.ot-imprint-handler{margin-right:8px}#onetrust-pc-sdk #ot-pc-desc a:hover{color:#1883fd}#onetrust-pc-sdk #ot-pc-desc button{margin-right:8px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-desc+.ot-link-btn{display:none}#onetrust-pc-sdk .ot-btn-subcntr{float:right}#onetrust-pc-sdk .ot-close-icon{background-size:12px;background-repeat:no-repeat;background-position:center;height:44px;width:44px;display:inline-block}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(21px);-ms-transform:translateX(21px);transform:translateX(21px);background-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0 1px #2196f3;outline-style:auto !important;outline-width:1px !important}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px;margin-bottom:0}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:\"\";height:18px;width:18px;bottom:3px;left:2px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox{z-index:1;position:relative;float:left}#onetrust-pc-sdk .ot-chkbox input{width:28px !important;height:28px !important}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:\"\"}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:\"\"}#onetrust-pc-sdk .ot-chkbox label{position:relative;padding-left:30px;display:flex;align-items:center;cursor:pointer;min-height:28px !important}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:\"\";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;left:4px;top:4px}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:8px;top:8px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-fltr-opt .ot-label-txt{display:inline-block}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-label-status{font-size:.75em;position:relative;top:2px;display:none;padding-right:5px;float:left}#onetrust-pc-sdk #ot-lst-cnt .ot-label-status{top:-6px}#onetrust-pc-sdk .ot-fltr-opts{min-height:35px}#onetrust-pc-sdk .ot-fltr-btns{margin:10px 15px 0 15px}#onetrust-pc-sdk .ot-fltr-btns button{padding:12px 30px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pc-footer button{margin-top:20px;margin-bottom:20px;font-weight:600;font-size:.813em;min-height:40px;height:auto;line-height:normal;padding:10px 30px}#onetrust-pc-sdk .ot-tab-desc{margin-left:3%}#onetrust-pc-sdk .ot-grp-hdr1{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-desc-cntr h4{color:#263238;display:inline-block;vertical-align:middle;margin:0;font-weight:bold;font-size:.875em;line-height:1.3;max-width:80%}#onetrust-pc-sdk .ot-subgrps .ot-subgrp h5{top:0;max-width:unset}#onetrust-pc-sdk #ot-pvcy-hdr{margin-bottom:10px}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-host-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{display:block;float:left;color:#3860be;font-size:.813em;font-weight:400;line-height:1.1;cursor:pointer;margin:5px 0px}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-host-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover{text-decoration-line:underline}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .category-host-list-handler,#onetrust-pc-sdk .ot-vlst-cntr,#onetrust-pc-sdk #ot-pc-desc+.category-vendors-list-handler{margin-top:8px}#onetrust-pc-sdk .ot-grp-hdr1+.ot-vlst-cntr{margin-top:0px;margin-bottom:10px}#onetrust-pc-sdk .ot-always-active-group h3.ot-cat-header,#onetrust-pc-sdk .ot-subgrp.ot-always-active-group>h4{max-width:70%}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr{max-width:28%}#onetrust-pc-sdk .ot-grp-desc ul,#onetrust-pc-sdk li.ot-subgrp p ul{margin:0px;margin-left:15px;padding-bottom:8px}#onetrust-pc-sdk .ot-grp-desc ul li,#onetrust-pc-sdk li.ot-subgrp p ul li{font-size:inherit;padding-top:8px;display:list-item;list-style:disc}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:inherit}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none;position:relative}#onetrust-pc-sdk ul.ot-subgrps li h5,#onetrust-pc-sdk ul.ot-subgrps li p{font-size:.82em;line-height:1.4}#onetrust-pc-sdk ul.ot-subgrps li p{color:dimgray;clear:both;float:left;margin-top:10px;margin-bottom:0;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul.ot-subgrps li h5{color:#263238;font-weight:bold;margin-bottom:0;float:left;position:relative;top:3px}#onetrust-pc-sdk li.ot-subgrp{margin-left:30px;display:inline-block;width:calc(100% - 30px)}#onetrust-pc-sdk .ot-subgrp-tgl{float:right}#onetrust-pc-sdk .ot-subgrp-tgl.ot-always-active-subgroup{width:auto}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4;border-radius:0 0 2px 2px}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk #accept-recommended-btn-handler{float:right;text-align:center}#onetrust-pc-sdk .save-preference-btn-handler{min-width:155px;background-color:#68b631;border-radius:2px;color:#fff;font-size:.9em;line-height:1.1;text-align:center;margin-left:15px;margin-right:15px}#onetrust-pc-sdk .ot-btn-subcntr button{margin-right:16px}#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr{white-space:normal;text-align:center;min-width:40%}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button{text-wrap:wrap;margin-left:auto;margin-right:auto;max-width:90%;width:90%}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button:nth-child(2){margin-top:0}#onetrust-pc-sdk.ot-ftr-stacked #accept-recommended-btn-handler{float:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{overflow:hidden}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container{display:flex;flex-wrap:wrap;justify-content:flex-end}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .ot-pc-refuse-all-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .ot-pc-refuse-all-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .save-preference-btn-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container #accept-recommended-btn-handler{float:none}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(1){min-width:155px;margin-left:15px;margin-right:auto}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(2),#onetrust-pc-sdk .ot-btn-container.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(3){margin-right:15px}#onetrust-pc-sdk #ot-pc-title{margin:0px;overflow:hidden;position:relative;line-height:1.2;max-height:2.4em;padding-right:1em;font-size:1.37em;text-overflow:ellipsis;white-space:nowrap;display:block;max-width:90%}#onetrust-pc-sdk #ot-pc-title.ot-pc-title-shrink{max-width:70%}#onetrust-pc-sdk #ot-pc-title-mobile{display:none !important}#onetrust-pc-sdk #ot-pc-lst{width:100%;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{padding-top:17px;padding-right:15px;padding-bottom:17px;padding-left:20px;display:inline-block;width:calc(100% - 35px);vertical-align:middle}#onetrust-pc-sdk #ot-pc-lst .ot-acc-txt{padding-top:6px;padding-right:15px;padding-bottom:10px;padding-left:20px}#onetrust-pc-sdk .ot-lst-cntr{height:100%}#onetrust-pc-sdk #ot-pc-hdr{padding-top:15px;padding-right:30px;padding-bottom:15px;padding-left:20px;display:inline-block;width:calc(100% - 50px);height:20px;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk #ot-pc-hdr input{height:32px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #ot-lst-cnt{height:calc(100% - 86px);padding-left:30px;padding-right:27px;padding-top:20px;margin-top:8px;margin-right:3px;margin-bottom:4px;margin-left:0;overflow-x:hidden;overflow-y:auto;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk #ot-lst-title{display:inline-block;font-size:1em}#onetrust-pc-sdk #ot-lst-title h3{color:dimgray;font-weight:bold;margin-left:10px;display:inline-block;font-size:1em}#onetrust-pc-sdk #ot-lst-title h3 *{font-size:inherit}#onetrust-pc-sdk .ot-lst-subhdr{float:right;position:relative;bottom:6px}#onetrust-pc-sdk #ot-search-cntr{display:inline-block;vertical-align:middle;position:relative;width:300px}#onetrust-pc-sdk #ot-search-cntr svg{position:absolute;right:0px;width:30px;height:30px;font-size:1em;line-height:1;top:2px}#onetrust-pc-sdk #ot-fltr-cntr{display:inline-block;position:relative;margin-left:20px;vertical-align:middle;font-size:0}#onetrust-pc-sdk #ot-filter-list-header{margin-top:15px;margin-bottom:10px;float:left;max-width:150px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px 1px 1px 15px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;width:32px;height:32px;padding:0;margin:0;position:relative}#onetrust-pc-sdk #filter-btn-handler svg{cursor:pointer;width:15px;height:15px;position:absolute;left:50%;top:50%;transform:translate(-50%, -50%);padding-top:5px}#onetrust-pc-sdk #filter-btn-handler path{fill:#fff}#onetrust-pc-sdk #ot-sel-blk{min-width:200px;min-height:30px;padding-left:20px}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr{float:left;height:100%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label{height:100%;padding-left:0}#onetrust-pc-sdk #ot-selall-hostcntr{width:21px;height:21px;position:relative;left:20px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;left:9px;top:12px;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none}#onetrust-pc-sdk .ot-ven-name,#onetrust-pc-sdk .ot-host-name{color:#2c3643;font-weight:bold;font-size:.813em;line-height:1.2;margin:0;height:auto;text-align:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-name *,#onetrust-pc-sdk .ot-host-name *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc{font-size:.69em;line-height:1.4;margin-top:5px;margin-bottom:5px;color:dimgray}#onetrust-pc-sdk .ot-host-name>a{text-decoration:underline;position:relative;z-index:2;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk .ot-host-hdr{float:left;width:calc(100% - 50px);pointer-events:none;position:relative;z-index:1}#onetrust-pc-sdk .ot-host-hdr .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr a{pointer-events:initial}#onetrust-pc-sdk .ot-host-hdr .ot-host-name~a{margin-top:5px;font-size:.813em;text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:88%;float:right}#onetrust-pc-sdk input:focus+.ot-acc-hdr{outline:#000 solid 1px !important}#onetrust-pc-sdk #ot-selall-hostcntr input[type=checkbox],#onetrust-pc-sdk #ot-selall-vencntr input[type=checkbox],#onetrust-pc-sdk #ot-selall-adtlvencntr input[type=checkbox]{position:absolute}#onetrust-pc-sdk .ot-host-item .ot-chkbox{float:left}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-hdr{right:38px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:auto;padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{right:2px;width:auto}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>.ot-acc-hdr{background:#f9f9fc;padding-top:10px;padding-bottom:10px;background-color:#f9f9fc}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>input[type=checkbox][aria-checked=mixed]~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk #ot-addtl-venlst .ot-tgl-cntr{margin-right:13px}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;display:inline-block}#onetrust-pc-sdk .ot-ven-item>button:focus,#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-ven-item>button,#onetrust-pc-sdk .ot-host-item>button,#onetrust-pc-sdk .ot-acc-cntr>button{position:absolute;cursor:pointer;width:100%;height:100%;border:0;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-ven-item>button~.ot-acc-hdr,#onetrust-pc-sdk .ot-host-item>button~.ot-acc-hdr,#onetrust-pc-sdk .ot-acc-cntr>button~.ot-acc-hdr{cursor:pointer}#onetrust-pc-sdk .ot-ven-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-host-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-ven-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-host-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;display:block}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk #ot-ven-lst,#onetrust-pc-sdk #ot-host-lst,#onetrust-pc-sdk #ot-addtl-venlst,#onetrust-pc-sdk #ot-gn-venlst{width:100%}#onetrust-pc-sdk #ot-ven-lst li,#onetrust-pc-sdk #ot-host-lst li,#onetrust-pc-sdk #ot-addtl-venlst li,#onetrust-pc-sdk #ot-gn-venlst li{border:1px solid #d7d7d7;border-radius:2px;position:relative;margin-top:10px}#onetrust-pc-sdk #ot-gn-venlst li.ot-host-info{padding:.5rem;overflow-y:hidden}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{width:65%}#onetrust-pc-sdk #ot-host-lst .ot-tgl-cntr{width:65%;float:left}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk .ot-host-notice{float:right}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link,#onetrust-pc-sdk .ot-host-expand{color:dimgray;font-size:.75em;line-height:.9;display:inline-block}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *,#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk .ot-host-opt{display:inline-block;width:100%;margin:0;font-size:inherit}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.81em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #ot-host-lst li.ot-host-info{border:none;font-size:.8em;color:dimgray;float:left;text-align:left;padding:10px;margin-bottom:10px;width:calc(100% - 10px);background-color:#f8f8f8}#onetrust-pc-sdk #ot-host-lst li.ot-host-info a{color:dimgray}#onetrust-pc-sdk #ot-host-lst li.ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk .ot-tgl-cntr{display:inline-block;vertical-align:middle}#onetrust-pc-sdk .ot-arw-cntr,#onetrust-pc-sdk .ot-tgl-cntr{float:right}#onetrust-pc-sdk .ot-desc-cntr{padding-top:0px;margin-top:20px;padding-right:0px;border-radius:3px;overflow:hidden;padding-bottom:10px}#onetrust-pc-sdk .ot-desc-cntr:focus,#onetrust-pc-sdk .ot-desc-cntr:active,#onetrust-pc-sdk .ot-desc-cntr:focus-visible{outline:2px solid #101010;border-radius:2px}#onetrust-pc-sdk .ot-leg-border-color{border:1px solid #e9e9e9}#onetrust-pc-sdk .ot-leg-border-color .ot-subgrp-cntr{border-top:1px solid #e9e9e9;padding-bottom:10px}#onetrust-pc-sdk .ot-category-desc{padding-bottom:10px}#onetrust-pc-sdk .ot-grp-hdr1{padding-left:10px;width:calc(100% - 20px);padding-top:10px;margin-bottom:0px;padding-bottom:8px}#onetrust-pc-sdk .ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk .ot-desc-cntr>*:not(.ot-grp-hdr1){padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-pli-hdr{overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;background-color:#f8f8f8;border:none;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-pli-hdr span:first-child{text-align:left;max-width:80px;padding-right:5px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:20px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-desc-cntr .ot-tgl-cntr:first-of-type,#onetrust-pc-sdk .ot-cat-header+.ot-tgl{padding-left:7px;padding-right:7px}#onetrust-pc-sdk .ot-always-active-group .ot-grp-hdr1 .ot-tgl-cntr:first-of-type{padding-left:0px}#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk .ot-subgrp h4{max-width:calc(100% - 133px)}#onetrust-pc-sdk #ot-lst-cnt #ot-sel-blk{width:100%;display:inline-block;padding:0}#onetrust-pc-sdk .ot-sel-all{display:inline-block;width:100%}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{width:100%;float:right;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk :not(.ot-hosts-ui) .ot-sel-all-hdr,#onetrust-pc-sdk :not(.ot-hosts-ui) .ot-sel-all-chkbox{right:23px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.813em;position:relative;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-hosts-ui .ot-consent-hdr{float:left;position:relative;left:5px}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;margin-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:10px}#onetrust-pc-sdk .ot-ven-litgl{margin-right:55px}#onetrust-pc-sdk .ot-ven-litgl.ot-ven-litgl-only{margin-right:86px}#onetrust-pc-sdk .ot-ven-ctgl,#onetrust-pc-sdk .ot-ven-litgl,#onetrust-pc-sdk .ot-ven-gvctgl{float:left}#onetrust-pc-sdk .ot-ven-ctgl label,#onetrust-pc-sdk .ot-ven-litgl label,#onetrust-pc-sdk .ot-ven-gvctgl label{width:22px;padding:0}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:21px;position:relative;float:right;right:80px}#onetrust-pc-sdk #ot-selall-licntr input{position:absolute}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-gnvencntr{float:right;width:21px;height:21px;position:relative;right:15px}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{float:right;width:auto}#onetrust-pc-sdk .ot-ven-hdr{float:left;width:60%}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;top:40px;right:35px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk #ot-fltr-modal{width:300px;position:absolute;z-index:2147483646;top:46px;height:90%;max-height:350px;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal button{max-width:200px;line-height:1;word-break:break-word;white-space:normal;height:auto;font-weight:bold}#onetrust-pc-sdk #ot-fltr-cnt{background-color:#fff;margin:5px;border-radius:3px;height:100%;margin-right:10px;padding-right:10px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;clear:both}#onetrust-pc-sdk .ot-fltr-opt .ot-chkbox{float:none}#onetrust-pc-sdk .ot-fltr-opt span{cursor:pointer;color:dimgray;font-size:.8em;line-height:1.1;font-weight:normal}#onetrust-pc-sdk #clear-filters-handler{float:right;margin-top:15px;margin-bottom:10px;text-decoration:none;color:#3860be;font-size:.9em;border:none;padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#1883fd}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk #filter-apply-handler{margin-right:10px}#onetrust-pc-sdk .ot-grp-desc+.ot-leg-btn-container{margin-top:0}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;line-height:normal;letter-spacing:0}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{border:none;text-decoration:underline;padding:0;font-size:.82em;font-weight:600;line-height:1.4;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:.91em;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;width:auto}#onetrust-pc-sdk.ot-close-btn-link .ot-close-cntr{right:5px;top:5px;transform:none}#onetrust-pc-sdk .ot-grps-cntr{overflow-y:hidden}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:50px}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:35px;height:10px}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{justify-content:flex-end}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all .ot-sel-all-chkbox{right:unset;display:flex;align-items:center}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all .ot-sel-all-chkbox #ot-selall-vencntr.ot-chkbox{right:unset}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all .ot-sel-all-chkbox{margin-left:12px}#onetrust-pc-sdk.otPcTab .ot-vs-selc-all .ot-sel-all-chkbox .sel-all-hdr{margin:0 1rem}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:\"\";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk.otPcTab[dir=rtl] input~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk.otPcTab[dir=rtl] #ot-back-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] #ot-search-cntr svg{right:15px}#onetrust-pc-sdk.otPcTab[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{padding:0;background-color:rgba(0,0,0,0);border:none;margin:0}@media(max-width: 767px){#onetrust-pc-sdk{width:100%;border:none}#onetrust-pc-sdk .ot-optout-signal{margin:.625rem}#onetrust-pc-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container{padding:0;margin:0}#onetrust-pc-sdk .ot-title-cntr{width:75%}#onetrust-pc-sdk .ot-title-cntr #ot-pc-title{white-space:break-spaces;font-size:20px;overflow-x:visible;margin-left:10px}#onetrust-pc-sdk .ot-pc-logo{width:15%}#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;font-size:10px}#onetrust-pc-sdk .ot-desc-cntr{margin:0;padding-top:20px;padding-right:20px;padding-bottom:15px;padding-left:20px;position:relative;left:auto}#onetrust-pc-sdk .ot-desc-cntr{margin-top:20px;margin-left:20px;padding:0;padding-bottom:10px}#onetrust-pc-sdk .ot-grps-cntr{max-height:none;overflow:hidden}#onetrust-pc-sdk #accept-recommended-btn-handler{float:none}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}#onetrust-pc-sdk.ot-tgl-with-label.ot-leg-opt-out .ot-pli-hdr{padding-right:8%}#onetrust-pc-sdk.ot-tgl-with-label .ot-cat-header{max-width:60%}#onetrust-pc-sdk.ot-tgl-with-label .ot-subgrp h4{max-width:58%}#onetrust-pc-sdk.ot-tgl-with-label .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp>h6{max-width:50%}#onetrust-pc-sdk.ot-tgl-with-label .ot-desc-cntr .ot-tgl-cntr:first-of-type,#onetrust-pc-sdk.ot-tgl-with-label .ot-cat-header+.ot-tgl{padding-left:15px}}@media(max-width: 640px){#onetrust-pc-sdk{height:100%}#onetrust-pc-sdk .ot-optout-signal{margin:.625rem}#onetrust-pc-sdk .ot-pc-header{padding:10px;width:calc(100% - 20px)}#onetrust-pc-sdk #ot-pc-content{overflow:auto}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-columns{width:100%}#onetrust-pc-sdk .ot-desc-cntr{margin:0;overflow:hidden}#onetrust-pc-sdk .ot-desc-cntr{margin-left:10px;width:calc(100% - 15px);margin-top:5px;margin-bottom:5px}#onetrust-pc-sdk .ot-ven-hdr{max-width:80%}#onetrust-pc-sdk #ot-lst-cnt{width:calc(100% - 18px);padding-top:13px;padding-right:5px;padding-left:10px}#onetrust-pc-sdk .ot-grps-cntr{width:100%}#onetrust-pc-sdk .ot-pc-footer{max-height:300px}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 322px)}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{position:fixed;top:10px;right:15px}#onetrust-pc-sdk.ot-close-btn-link .ot-pc-header{padding-top:25px}#onetrust-pc-sdk.ot-close-btn-link #ot-pc-title{max-width:100%}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(1){margin-right:15px}#onetrust-pc-sdk #ot-pc-title-mobile{display:block !important;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%;padding-left:12px}#onetrust-pc-sdk #ot-pc-title{display:none !important}#onetrust-pc-sdk .ot-pc-logo{width:180px !important}#onetrust-pc-sdk .ot-title-cntr{float:right;width:auto !important}#onetrust-pc-sdk .ot-close-cntr{transform:translateY(0%)}}@media(max-width: 640px)and (orientation: portrait){#onetrust-pc-sdk #ot-pc-hdr{height:70px;padding:15px 0;width:100%}#onetrust-pc-sdk .ot-lst-subhdr{width:calc(100% - 15px);float:none;bottom:auto;display:inline-block;padding-top:8px;padding-left:15px}#onetrust-pc-sdk .ot-btn-subcntr{float:none}#onetrust-pc-sdk #ot-search-cntr{display:inline-block;width:calc(100% - 55px);position:relative}#onetrust-pc-sdk #ot-anchor{top:75px;right:30px}#onetrust-pc-sdk #ot-fltr-modal{top:81px}#onetrust-pc-sdk #ot-fltr-cntr{float:right;right:15px}#onetrust-pc-sdk #ot-lst-title{padding-left:15px}#onetrust-pc-sdk #ot-lst-cnt{height:auto;overflow:auto}#onetrust-pc-sdk .save-preference-btn-handler,#onetrust-pc-sdk #accept-recommended-btn-handler,#onetrust-pc-sdk .ot-pc-refuse-all-handler{width:calc(100% - 33px) !important}#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr{max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{margin:15px}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button{min-width:none;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button:nth-child(2){margin-top:15px}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container button:not(:last-child){margin-bottom:0}}@media(max-width: 425px){#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{width:150px img;width-max-height:100%;width-font-size:10px}#onetrust-pc-sdk .ot-title-cntr{width:75%}#onetrust-pc-sdk #ot-pc-lst .ot-acc-txt{padding-top:6px;padding-bottom:10px}#onetrust-pc-sdk #ot-pc-lst .ot-host-notice{float:left;margin-left:30px}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:none;display:inline}#onetrust-pc-sdk #ot-pc-lst .ot-ven-hdr{float:left;width:100%;max-width:85%}#onetrust-pc-sdk.ot-addtl-vendors #ot-pc-lst .ot-acc-cntr .ot-arw-cntr:first-of-type{float:right}#onetrust-pc-sdk #ot-pc-title{max-width:100%;white-space:break-spaces;font-size:20px;overflow-x:visible}#onetrust-pc-sdk .ot-subgrp-cntr li.ot-subgrp{margin-left:10px;width:calc(100% - 10px)}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{width:auto;float:right}#onetrust-pc-sdk #ot-ven-lst .ot-arw-cntr{float:right}#onetrust-pc-sdk .ot-ven-hdr{max-width:47%}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr:first-of-type{max-width:none;padding-left:20px}}@media only screen and (max-height: 425px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk{height:100%;width:100%;max-width:none}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr{max-width:none}#onetrust-pc-sdk .ot-pc-header{padding:10px;width:calc(100% - 20px);height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:20px;width:20%}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo img{max-height:100%;font-size:10px}#onetrust-pc-sdk .ot-title-cntr{width:75%}#onetrust-pc-sdk .ot-title-cntr #ot-pc-title{white-space:break-spaces;font-size:20px;overflow-x:visible}#onetrust-pc-sdk .ot-pc-footer{max-height:52px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-lst{overflow-y:auto}#onetrust-pc-sdk #ot-pc-lst #ot-pc-hdr{height:auto}#onetrust-pc-sdk #ot-pc-lst #ot-pc-hdr #ot-pc-title{max-height:20px}#onetrust-pc-sdk #ot-pc-lst #ot-pc-hdr .ot-lst-subhdr{padding:10px 5px;float:none}#onetrust-pc-sdk #ot-pc-lst #ot-pc-hdr .ot-lst-subhdr #ot-fltr-cntr{margin-top:5px}#onetrust-pc-sdk #ot-pc-lst #ot-lst-cnt{overflow:visible}#onetrust-pc-sdk #ot-lst-cnt{height:auto;overflow:auto}#onetrust-pc-sdk #accept-recommended-btn-handler{float:right}#onetrust-pc-sdk .save-preference-btn-handler,#onetrust-pc-sdk #accept-recommended-btn-handler,#onetrust-pc-sdk .ot-pc-refuse-all-handler{width:auto}#onetrust-pc-sdk.ot-ftr-stacked #accept-recommended-btn-handler,#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{width:90%}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 120px)}#onetrust-pc-sdk.ot-shw-fltr .ot-lst-cntr{overflow:hidden}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{position:static}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-modal{top:0;width:100%;height:100%;max-height:none}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-modal>div{margin:0;box-sizing:initial;height:100%;max-height:none}#onetrust-pc-sdk.ot-shw-fltr #clear-filters-handler{padding-right:20px}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk .ot-pc-footer button{margin:10px}}@media(max-width: 425px),(max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk .ot-pc-header{padding-right:20px}#onetrust-pc-sdk .ot-pc-logo{margin-left:0px;margin-top:5px;width:150px}#onetrust-pc-sdk .ot-close-icon{width:44px;height:44px;background-size:12px}#onetrust-pc-sdk .ot-grp-hdr1{float:right;padding-right:10px}#onetrust-pc-sdk .ot-grp-hdr1+.ot-vlst-cntr{padding-top:10px}}@media only screen and (max-height: 610px){#onetrust-pc-sdk{max-height:100%}}@media(max-width: 425px)and (orientation: landscape){#onetrust-pc-sdk .ot-pc-header #ot-pc-title{font-size:10px}}\n            #onetrust-consent-sdk #onetrust-pc-sdk,\n                #onetrust-consent-sdk #ot-search-cntr,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,\n                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after\n                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,\n                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,\n                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {\n                    background-color: #FFFFFF;\n                }\n               \n            #onetrust-consent-sdk #onetrust-pc-sdk h3,\n                #onetrust-consent-sdk #onetrust-pc-sdk h4,\n                #onetrust-consent-sdk #onetrust-pc-sdk h5,\n                #onetrust-consent-sdk #onetrust-pc-sdk h6,\n                #onetrust-consent-sdk #onetrust-pc-sdk p,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,\n                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,\n                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal\n                {\n                    color: #3b3b3b;\n                }\n             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a,\n                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc a\n                    {\n                        color: #3860BE;\n                    }\n            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle\n             {\n                background-color: #ffffff;\n            }\n             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,\n                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets\n                            {\n                                background-color: #ffffff;\n                            }\n        #onetrust-consent-sdk #onetrust-pc-sdk\n            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {\n                background-color: #c50f3c;border-color: #c50f3c;\n                color: #FFFFFF;\n            }\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {\n                border-color: #c50f3c;\n            }\n            \n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{\n                background-color: transparent;\n                border: 1px solid transparent;\n            }\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {\n                background-color: #FFFFFF;\n                color: #4D4D4D; border-color: #4D4D4D;\n            }#onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob {\n                background-color: #468254;\n            }\n                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch-nob {\n                    background-color: #767676;\n                }\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,\n            #onetrust-pc-sdk .ot-checkbox input[type=\"checkbox\"]:focus + label::before,\n            #onetrust-pc-sdk .ot-chkbox input[type=\"checkbox\"]:focus + label::before {\n                outline-color: #000000;\n                outline-width: 1px;\n                outline-offset: 1px;\n            }\n            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {\n                border: 1px solid #000000;\n            }\n            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,\n            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {\n               outline: 1px solid #000000;\n               outline-offset: 1px;\n            }#onetrust-consent-sdk #onetrust-pc-sdk .category-menu-switch-handler {\n                    background-color: #ffffff\n                }#onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {\n                    background-color: #FFFFFF\n                }#onetrust-consent-sdk #onetrust-pc-sdk .category-menu-switch-handler {\n                    background-color: #ffffff\n                }#onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {\n                    background-color: #FFFFFF\n                }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{\n                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');\n                }\n            #onetrust-pc-sdk .ot-pc-footer #accept-recommended-btn-handler {\n    background-color:#c50f3c  !important;\n    color: #FFFFFF !important;\n    border-color: #c50f3c !important;\n}\n\n#onetrust-pc-sdk .ot-btn-subcntr button {\n    background-color: #203662;\n    color: #FFFFFF;\n    border-color: #203662;\n}\n\n#onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {\n    border-color: #203662;\n}\n#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns {\nwidth: 60%;\n}\n#onetrust-pc-sdk li h3 {\ncolor: #203662;\n}\n#onetrust-pc-sdk #ot-pc-title {\nmax-height:none;\n}\n#onetrust-pc-sdk .category-menu-switch-handler h3 {\ncolor: #203662 !important; \n}\n\n@media (max-width: 640px) {\n#onetrust-pc-sdk .ot-desc-cntr {\ntop: -45px;\n}\n#ot-pc-desc.ot-grp-desc {\nmargin-top: 60px;\n}\n#onetrust-pc-sdk .ot-category-desc {\npadding-top: 60px;\n}\n#onetrust-pc-sdk .ot-desc-cntr h3 {\ndisplay: none;\n}\n}\n@media only screen and (min-width: 320px) and (max-width: 640px)\n { \n     #onetrust-pc-sdk #ot-pvcy-hdr {display:none !important;}\n     h4.ot-cat-header {display:none !important;}\n}\n#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob { background-color: #65c466 !important;\n}\n\n#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before {\n   background-color: #FFFF !important;\n    border:1px solid #000 !important;\n}\n\n#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob {  background-color: #65c466 !important;\n}\nbutton.ot-pc-refuse-all-handler {\nbackground-color: #c50f3c !important;\nborder-color: #c50f3c !important;\n}\n@media (min-width: 640px) {\n#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler {\n    min-width: 24.77%;\n}\n#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button {\n    margin-left: 42px;\n    margin-right: 16px;\n    width: 66.8%;\n}\n#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr {\n    min-width: 24.2%;\n}\n}\n@media (max-width: 450px) {\n#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler {\nmin-width: 94%;\n}\n#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr {\nwidth: 100%;\n}\n#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button {\nmin-width: 94%;\n}\n}\n@media only screen and (min-width: 320px) and (max-width: 640px)\n{ \n     #onetrust-pc-sdk #ot-pvcy-hdr {display:none !important;}\n     h4.ot-cat-header {display:none !important;}\n}\n/*#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,\n#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,\n#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns {\n  width: 34.666667% !important;\n}*/\n#ot-sdk-btn-floating.ot-floating-button {\n    width: 46px !important;\n    height: 21px !important;\n    @media(max-width: 768px) {\n        width: 38px !important;\n        height: 18px !important;\n    }\n}\n#ot-sdk-btn-floating .ot-floating-button__back svg {\n    width: 46px  !important;\n    height: 18px !important;\n    @media(max-width: 768px) {\n        width: 38px !important;\n        height: 15px !important;\n    }\n}.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}\n                \n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {\n                        color: #696969;\n                    }\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {\n                        color: #696969;\n                    }\n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {\n                        color: #696969;\n                    }\n                    \n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {\n                            color: #696969;\n                        }\n                    \n            \n                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {\n                            background-color: #F8F8F8;\n                        }\n                    \n            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/bf68afa0-3c8d-4d2e-9472-6b54f14f5822/0198f489-85a2-7c90-a11b-b540a769510d/764d6f0c-69e4-4e24-ac74-ad66927f9cfd/Desktop_1.png')}\n        @keyframes slide-down-custom {\n            0% {\n                bottom: 945px !important;\n            }\n            100% {\n                bottom: 0px;\n            }\n        }\n        @-webkit-keyframes slide-down-custom {\n            0% {\n                bottom: 945px !important;\n            }\n            100% {\n                bottom: 0px;\n            }\n        }\n        @-moz-keyframes slide-down-custom {\n            0% {\n                bottom: 945px !important;\n            }\n            100% {\n                bottom: 0px;\n            }\n        }\n        #ot-sdk-btn-floating.ot-floating-button{position:fixed;bottom:10px;opacity:0;width:50px;height:50px;line-height:15px;cursor:pointer;background-color:rgba(0,0,0,0);transition:all 300ms ease;z-index:2147483646;animation:otFloatingBtnIntro 800ms ease 0ms 1 forwards}#ot-sdk-btn-floating.ot-floating-button.ot-hide{display:none}#ot-sdk-btn-floating.ot-floating-button::before,#ot-sdk-btn-floating.ot-floating-button::after{text-transform:none;line-height:1;user-select:none;pointer-events:none;position:absolute;transform:scale(0);opacity:0;transition:all 300ms ease;display:block;height:auto}#ot-sdk-btn-floating.ot-floating-button::before{content:\"\";border:5px solid rgba(0,0,0,0);z-index:1001;top:50%;border-left-width:0;border-right-color:#333;right:calc(0em - 5px);transform:translate(10px, -50%)}#ot-sdk-btn-floating.ot-floating-button::after{content:attr(data-title);position:absolute;text-align:center;top:50%;left:calc(100% + 5px);transform:translate(10px, -50%);font-size:.75rem;min-width:3em;max-width:21em;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;padding:5px;border-radius:.3ch;box-shadow:0 1em 2em -0.5em rgba(0,0,0,.35);background:#333;color:#fff;z-index:2147483645}#ot-sdk-btn-floating.ot-floating-button:hover::before,#ot-sdk-btn-floating.ot-floating-button:hover::after{opacity:1}#ot-sdk-btn-floating.ot-floating-button:hover::before{transform:translate(0.5em, -50%) scale(1)}#ot-sdk-btn-floating.ot-floating-button:hover::after{transform:translate(0.5em, -50%) scale(1)}#ot-sdk-btn-floating.ot-floating-button.ot-pc-open .ot-floating-button__front{transform:rotateY(-180deg)}#ot-sdk-btn-floating.ot-floating-button.ot-pc-open .ot-floating-button__back{transform:rotateY(0)}#ot-sdk-btn-floating .ot-floating-button__front,#ot-sdk-btn-floating .ot-floating-button__back{position:absolute;width:100%;height:100%;-webkit-backface-visibility:hidden;backface-visibility:hidden;background-color:#6aaae4;border-radius:10px;box-shadow:0 4px 8px 0 rgba(0,0,0,.2);transition:transform .6s;transform-style:preserve-3d}#ot-sdk-btn-floating .ot-floating-button__front{background-color:#6aaae4;transform:rotateY(0)}#ot-sdk-btn-floating .ot-floating-button__front.custom-persistent-icon{background-position:center center;background-repeat:no-repeat;background-size:100%;border-radius:100px}#ot-sdk-btn-floating .ot-floating-button__front svg:not(.ot-source-sprite){width:30px;height:37px}#ot-sdk-btn-floating .ot-floating-button__front svg.ot-source-sprite{width:50px;height:50px}#ot-sdk-btn-floating .ot-floating-button__back{background-color:#fff;transform:rotateY(-180deg)}#ot-sdk-btn-floating .ot-floating-button__back.custom-persistent-icon{background-position:center center;background-repeat:no-repeat;background-size:100%;border-radius:100px}#ot-sdk-btn-floating .ot-floating-button__back svg{width:24px;height:24px}#ot-sdk-btn-floating.ot-floating-button button{padding:0;background-color:rgba(0,0,0,0);border:0;width:100%;height:100%;cursor:pointer}#ot-sdk-btn-floating.ot-floating-button button>*{pointer-events:none}@keyframes otFloatingBtnIntro{0%{opacity:0;left:-75px}100%{opacity:1;left:1%}}@keyframes otFloatingBtnImageIntro{0%{opacity:0;transform:scale(0) rotate(-270deg)}100%{opacity:100%;transform:scale(0.95) rotate(0deg)}}</style></head>\n<body class=\"default-device bodyclass\">\n    \n\n\n\n <noscript>\n     <iframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-TZLH92\"\n             height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n </noscript>\n    \n<!-- #wrapper -->\n<div id=\"gl-wrapper\">\n  <!-- #header -->\n  <header>\n    <div id=\"header\" class=\"container\">\n      <div class=\"row\">\n        \n\n\n\n\n<section class=\"component container col-xl-12 g-header-component\">\n    <div class=\"component-content\">\n\n<div class=\"row component column-splitter\">\n        <div class=\" col g-header-logo\">\n            \n\n<div class=\"component image file-type-icon-media-link col-xl-12\">\n    <div class=\"component-content\">\n<a title=\"Image 1\" href=\"/\" class=\"gilead-corporate-header\"><img width=\"168\" height=\"45\" alt=\"All-Pages-Gilead-logo\" src=\"https://gilead.stylelabs.cloud/api/public/content/89749f3b535e4eebb8ae07c8e9607b17?v=c1371898\" stylelabs-content-id=\"267124\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/267124/thumbnail\" data-variantitemid=\"{E917124D-403E-41F8-8F1B-4787517F6E2B}\" format=\"\" data-variantfieldname=\"Image\"></a>    </div>\n</div>\n\n        </div>\n        <div class=\" col g-header-navigation\">\n            \n<div class=\"row component column-splitter\">\n        <div class=\"col-lg-9 col-xl-9 col-xxl-9 g-main-navigation\">\n            \n    <div class=\"component navigation navigation-title col-xl-12 navigation-main navigation-main-horizontal initialized\">\n        <div class=\"component-content\">\n            <nav>\n\n<ul class=\"clearfix\">\n        <li class=\"level1 submenu item0 odd first active rel-level1\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science\" class=\"gilead-corporate-header\">\n   Science\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level2 item0 odd first rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/overview\" class=\"gilead-corporate-header\">\n   Science\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item1 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas\" class=\"gilead-corporate-header\">\n   Therapeutic Areas\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/overview\" class=\"gilead-corporate-header\">\n   Therapeutic Areas\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/virology\" class=\"gilead-corporate-header\">\n   Virology\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/virology/overview\" class=\"gilead-corporate-header\">\n   Virology\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/virology/hiv\" class=\"gilead-corporate-header\">\n   HIV\n</a>\n</div>        </li>\n        <li class=\" level4 item2 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/virology/viral-hepatitis\" class=\"gilead-corporate-header\">\n   Viral Hepatitis\n</a>\n</div>        </li>\n        <li class=\" level4 item3 even last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/virology/neglected-and-emerging-viruses-and-pandemic-preparedness\" class=\"gilead-corporate-header\">\n   Neglected &amp; Emerging Viruses and Pandemic Preparedness \n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level3 item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/oncology\" class=\"gilead-corporate-header\">\n   Oncology\n</a>\n</div>        </li>\n        <li class=\" level3 item3 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/therapeutic-areas/inflammation\" class=\"gilead-corporate-header\">\n   Inflammation\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item2 odd active rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/pipeline\" class=\"gilead-corporate-header\">\n   Pipeline\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item3 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research\" class=\"gilead-corporate-header\">\n   Research\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/overview\" class=\"gilead-corporate-header\">\n   Research\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/our-r-and-d-approach\" class=\"gilead-corporate-header\">\n   Our R&amp;D Approach\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs\" class=\"gilead-corporate-header\">\n   Research Funding Programs\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/overview\" class=\"gilead-corporate-header\">\n   Research Funding Programs\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/research-scholars-program\" class=\"gilead-corporate-header\">\n   Research Scholars Program\n</a>\n</div>        </li>\n        <li class=\"level4 submenu item2 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/external-sponsored-research\" class=\"gilead-corporate-header\">\n   External-Sponsored Research\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level5 item0 odd first rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/external-sponsored-research/overview\" class=\"gilead-corporate-header\">\n   External-Sponsored Research\n</a>\n</div>        </li>\n        <li class=\" level5 item1 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/external-sponsored-research/virology-rfp-opportunities\" class=\"gilead-corporate-header\">\n   Virology RFP Opportunities\n</a>\n</div>        </li>\n        <li class=\" level5 item2 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/external-sponsored-research/oncology-rfp-opportunities\" class=\"gilead-corporate-header\">\n   Oncology RFP Opportunities\n</a>\n</div>        </li>\n        <li class=\" level5 item3 even last rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/external-sponsored-research/inflammation-rfp-opportunities\" class=\"gilead-corporate-header\">\n   Inflammation RFP Opportunities\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level4 item3 even last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-funding-programs/community-based-participatory-research\" class=\"gilead-corporate-header\">\n   Community-Based Participatory Research\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level3 item3 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/research/research-publications\" class=\"gilead-corporate-header\">\n   Research Publications\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"external-link level2 item4 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/clinical-trials\" class=\"gilead-corporate-header\" target=\"_blank\">\n   Clinical Trials\n</a>\n</div>        </li>\n        <li class=\" level2 item5 even last rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/science/diversity-in-clinical-trials\" class=\"gilead-corporate-header\">\n   Diversity in Clinical Trials\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level1 submenu item1 even rel-level1\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines\" class=\"gilead-corporate-header\">\n   Medicines\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level2 item0 odd first rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/overview\" class=\"gilead-corporate-header\">\n   Medicines\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item1 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/patient-safety\" class=\"gilead-corporate-header\">\n   Patient Safety\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/patient-safety/overview\" class=\"gilead-corporate-header\">\n   Patient Safety\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/patient-safety/anti-counterfeiting\" class=\"gilead-corporate-header\">\n   Anti-Counterfeiting\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/patient-safety/consumer-product-safety\" class=\"gilead-corporate-header\">\n   Consumer Product Safety\n</a>\n</div>        </li>\n        <li class=\" level3 item3 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/patient-safety/report-an-adverse-event\" class=\"gilead-corporate-header\">\n   Report an Adverse Event\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item2 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/medication-access\" class=\"gilead-corporate-header\">\n   Medication Access\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/medication-access/overview\" class=\"gilead-corporate-header\">\n   Medication Access\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/medication-access/us-patient-access\" class=\"gilead-corporate-header\">\n   U.S. Patient Access\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/medication-access/managed-access\" class=\"gilead-corporate-header\">\n   Managed Access\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item3 even last rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/medicines/authorized-distributors\" class=\"gilead-corporate-header\">\n   Authorized Distributors\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level1 submenu item2 odd rel-level1\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility\" class=\"gilead-corporate-header\">\n   Responsibility\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level2 item0 odd first rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/overview\" class=\"gilead-corporate-header\">\n   Responsibility\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item1 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/esg\" class=\"gilead-corporate-header\">\n   ESG\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/esg/overview\" class=\"gilead-corporate-header\">\n   ESG\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/esg/esg-performance\" class=\"gilead-corporate-header\">\n   ESG Performance\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/esg/esg-focus-areas\" class=\"gilead-corporate-header\">\n   ESG Focus Areas\n</a>\n</div>        </li>\n        <li class=\" level3 item3 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/esg/esg-frameworks-and-reporting\" class=\"gilead-corporate-header\">\n   ESG Frameworks and Reporting\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item2 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/sustainability\" class=\"gilead-corporate-header\">\n   Sustainability\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/sustainability/overview\" class=\"gilead-corporate-header\">\n   Sustainability\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/sustainability/sustainability-focus-areas\" class=\"gilead-corporate-header\">\n   Sustainability Focus Areas\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item3 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/health-equity\" class=\"gilead-corporate-header\">\n   Health Equity\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item4 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead\" class=\"gilead-corporate-header\">\n   Giving@Gilead\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/overview\" class=\"gilead-corporate-header\">\n   Giving@Gilead\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving\" class=\"gilead-corporate-header\">\n   Corporate Giving\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/overview\" class=\"gilead-corporate-header\">\n   Corporate Giving\n</a>\n</div>        </li>\n        <li class=\"level4 submenu item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives\" class=\"gilead-corporate-header\">\n   Strategic Initiatives\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level5 item0 odd first rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/overview\" class=\"gilead-corporate-header\">\n   Strategic Initiatives\n</a>\n</div>        </li>\n        <li class=\"external-link level5 item1 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/all4liver\" class=\"gilead-corporate-header\" target=\"_blank\">\n   All4Liver\n</a>\n</div>        </li>\n        <li class=\"external-link level5 item2 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/asia-pacific-rainbow-grant\" class=\"gilead-corporate-header\" target=\"_blank\">\n   Asia Pacific Rainbow Grant\n</a>\n</div>        </li>\n        <li class=\" level5 item3 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/compass-initiative\" class=\"gilead-corporate-header\">\n   COMPASS Initiative\n</a>\n</div>        </li>\n        <li class=\" level5 item4 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hepconnect\" class=\"gilead-corporate-header\">\n   HepConnect\n</a>\n</div>        </li>\n        <li class=\" level5 item5 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hiv-age-positively\" class=\"gilead-corporate-header\">\n   HIV Age Positively\n</a>\n</div>        </li>\n        <li class=\" level5 item6 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/radian\" class=\"gilead-corporate-header\">\n   RADIAN\n</a>\n</div>        </li>\n        <li class=\" level5 item7 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/setting-the-pace\" class=\"gilead-corporate-header\">\n   Setting the P.A.C.E.- Prevention, Arts and Advocacy, Community, Education\n</a>\n</div>        </li>\n        <li class=\" level5 item8 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/gilead-oncology-grant\" class=\"gilead-corporate-header\">\n   Gilead Oncology Grant\n</a>\n</div>        </li>\n        <li class=\" level5 item9 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/toward-health-equity-for-black-people-impacted-by-tnbc\" class=\"gilead-corporate-header\">\n   Toward Health Equity for Black People Impacted by TNBC\n</a>\n</div>        </li>\n        <li class=\" level5 item10 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/transcend\" class=\"gilead-corporate-header\">\n   TRANScend\n</a>\n</div>        </li>\n        <li class=\" level5 item11 even last rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/zeroing-in-ending-the-hiv-epidemic\" class=\"gilead-corporate-header\">\n   Zeroing In: Ending the HIV Epidemic\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level4 submenu item2 odd last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding\" class=\"gilead-corporate-header\">\n   How to Apply for Funding\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level5 item0 odd first rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/overview\" class=\"gilead-corporate-header\">\n   How to Apply for Funding\n</a>\n</div>        </li>\n        <li class=\" level5 item1 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-africa\" class=\"gilead-corporate-header\">\n   Giving in Africa\n</a>\n</div>        </li>\n        <li class=\" level5 item2 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-asia\" class=\"gilead-corporate-header\">\n   Giving in Asia\n</a>\n</div>        </li>\n        <li class=\" level5 item3 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-australia\" class=\"gilead-corporate-header\">\n   Giving in Australia\n</a>\n</div>        </li>\n        <li class=\" level5 item4 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-europe-and-the-middle-east\" class=\"gilead-corporate-header\">\n   Giving in Europe &amp; the Middle East\n</a>\n</div>        </li>\n        <li class=\" level5 item5 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-latin-america-and-the-caribbean\" class=\"gilead-corporate-header\">\n   Giving in Latin America &amp; the Caribbean\n</a>\n</div>        </li>\n        <li class=\" level5 item6 odd rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-north-america\" class=\"gilead-corporate-header\">\n   Giving in North America\n</a>\n</div>        </li>\n        <li class=\" level5 item7 even rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/terms-and-conditions\" class=\"gilead-corporate-header\">\n   Terms &amp; Conditions\n</a>\n</div>        </li>\n        <li class=\" level5 item8 odd last rel-level5\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/faqs\" class=\"gilead-corporate-header\">\n   FAQs\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n        </li>\n        <li class=\"level3 submenu item2 odd last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/gilead-foundation\" class=\"gilead-corporate-header\">\n   Gilead Foundation\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/gilead-foundation/overview\" class=\"gilead-corporate-header\">\n   Gilead Foundation\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/gilead-foundation/creating-possible-fund\" class=\"gilead-corporate-header\">\n   Creating Possible Fund\n</a>\n</div>        </li>\n        <li class=\" level4 item2 odd last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/giving-at-gilead/gilead-foundation/building-community-donations\" class=\"gilead-corporate-header\">\n   Building Community Donations\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item5 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access\" class=\"gilead-corporate-header\">\n   Global Health and Access\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/overview\" class=\"gilead-corporate-header\">\n   Global Health and Access\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/focus\" class=\"gilead-corporate-header\">\n   FOCUS\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item2 odd last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/access-in-low--and-middle-income-countries\" class=\"gilead-corporate-header\">\n   Access in Low- and Middle-Income Countries\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/overview\" class=\"gilead-corporate-header\">\n   Access in Low- and Middle-Income Countries\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/access-strategy-for-long-acting-prep\" class=\"gilead-corporate-header\">\n   Access Strategy for Long-Acting PrEP\n</a>\n</div>        </li>\n        <li class=\" level4 item2 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/invasive-fungal-infection\" class=\"gilead-corporate-header\">\n   Invasive Fungal Infections\n</a>\n</div>        </li>\n        <li class=\" level4 item3 even last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/global-health-and-access/access-in-low--and-middle-income-countries/access-partnerships\" class=\"gilead-corporate-header\">\n   Access Partnerships\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item6 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity\" class=\"gilead-corporate-header\">\n   Inclusion and Diversity\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/overview\" class=\"gilead-corporate-header\">\n   Inclusion and Diversity\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups\" class=\"gilead-corporate-header\">\n   Employee Resource Groups\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/overview\" class=\"gilead-corporate-header\">\n   Employee Resource Groups\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/adapt\" class=\"gilead-corporate-header\">\n   ADAPT\n</a>\n</div>        </li>\n        <li class=\" level4 item2 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/gain\" class=\"gilead-corporate-header\">\n   GAIN\n</a>\n</div>        </li>\n        <li class=\" level4 item3 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/gileados\" class=\"gilead-corporate-header\">\n   Gileados\n</a>\n</div>        </li>\n        <li class=\" level4 item4 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/globe\" class=\"gilead-corporate-header\">\n   GLOBE\n</a>\n</div>        </li>\n        <li class=\" level4 item5 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/gvet\" class=\"gilead-corporate-header\">\n   GVET\n</a>\n</div>        </li>\n        <li class=\" level4 item6 odd rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/pride-alliance\" class=\"gilead-corporate-header\">\n   Pride Alliance\n</a>\n</div>        </li>\n        <li class=\" level4 item7 even last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/inclusion-and-diversity/employee-resource-groups/women-at-gilead\" class=\"gilead-corporate-header\">\n   Women at Gilead\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n        </li>\n        <li class=\" level2 item7 even last rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/responsibility/medical-education\" class=\"gilead-corporate-header\">\n   Medical Education\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level1 item3 even rel-level1 no-child\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/stories\" class=\"gilead-corporate-header\">\n   Stories\n</a>\n</div>        </li>\n        <li class=\"level1 submenu item4 odd rel-level1\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company\" class=\"gilead-corporate-header\">\n   Company\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level2 item0 odd first rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/overview\" class=\"gilead-corporate-header\">\n   Company\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item1 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership\" class=\"gilead-corporate-header\">\n   Leadership\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/overview\" class=\"gilead-corporate-header\">\n   View All Leaders\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/daniel-oday\" class=\"gilead-corporate-header\">\n   Daniel O\u2019Day\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/andrew-dickinson\" class=\"gilead-corporate-header\">\n   Andrew Dickinson\n</a>\n</div>        </li>\n        <li class=\" level3 item3 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/stacey-ma\" class=\"gilead-corporate-header\">\n   Stacey Ma\n</a>\n</div>        </li>\n        <li class=\" level3 item4 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/dietmar-berger\" class=\"gilead-corporate-header\">\n   Dietmar Berger, MD, PhD\n</a>\n</div>        </li>\n        <li class=\" level3 item5 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/flavius-martin\" class=\"gilead-corporate-header\">\n   Flavius Martin, MD\n</a>\n</div>        </li>\n        <li class=\" level3 item6 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/jyoti-mehra\" class=\"gilead-corporate-header\">\n   Jyoti Mehra\n</a>\n</div>        </li>\n        <li class=\" level3 item7 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/johanna-mercier\" class=\"gilead-corporate-header\">\n   Johanna Mercier\n</a>\n</div>        </li>\n        <li class=\" level3 item8 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/cindy-perettie\" class=\"gilead-corporate-header\">\n   Cindy Perettie\n</a>\n</div>        </li>\n        <li class=\" level3 item9 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/leadership/deborah-telman\" class=\"gilead-corporate-header\">\n   Deborah H. Telman\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item2 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors\" class=\"gilead-corporate-header\">\n   Board of Directors\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/overview\" class=\"gilead-corporate-header\">\n   View All Directors\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/daniel-oday\" class=\"gilead-corporate-header\">\n   Daniel O\u2019Day\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/jacqueline-barton\" class=\"gilead-corporate-header\">\n   Jacqueline K. Barton, PhD\n</a>\n</div>        </li>\n        <li class=\" level3 item3 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/jeffrey-bluestone\" class=\"gilead-corporate-header\">\n   Jeffrey A. Bluestone, PhD\n</a>\n</div>        </li>\n        <li class=\" level3 item4 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/sandra-horning\" class=\"gilead-corporate-header\">\n   Sandra J. Horning, MD\n</a>\n</div>        </li>\n        <li class=\" level3 item5 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/kelly-kramer\" class=\"gilead-corporate-header\">\n   Kelly A. Kramer\n</a>\n</div>        </li>\n        <li class=\" level3 item6 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/ted-love\" class=\"gilead-corporate-header\">\n   Ted W. Love, MD\n</a>\n</div>        </li>\n        <li class=\" level3 item7 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/harish-manwani\" class=\"gilead-corporate-header\">\n   Harish Manwani\n</a>\n</div>        </li>\n        <li class=\" level3 item8 odd rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/javier-rodriguez\" class=\"gilead-corporate-header\">\n   Javier J. Rodriguez\n</a>\n</div>        </li>\n        <li class=\" level3 item9 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-of-directors/anthony-welters\" class=\"gilead-corporate-header\">\n   Anthony Welters\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item3 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/board-governance-and-committees\" class=\"gilead-corporate-header\">\n   Board Governance and Committees\n</a>\n</div>        </li>\n        <li class=\" level2 item4 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/investing-in-the-us\" class=\"gilead-corporate-header\">\n   Investing in the U.S.\n</a>\n</div>        </li>\n        <li class=\" level2 item5 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/media\" class=\"gilead-corporate-header\">\n   Media\n</a>\n</div>        </li>\n        <li class=\" level2 item6 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/ethics-and-compliance\" class=\"gilead-corporate-header\">\n   Ethics and Compliance\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item7 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/policies-and-procedures\" class=\"gilead-corporate-header\">\n   Policies and Procedures\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/policies-and-procedures/overview\" class=\"gilead-corporate-header\">\n   Policies and Procedures\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/policies-and-procedures/ai-principles\" class=\"gilead-corporate-header\">\n   AI Principles\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item8 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/disclosures\" class=\"gilead-corporate-header\">\n   Disclosures\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item9 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/us-public-policy-engagement\" class=\"gilead-corporate-header\">\n   U.S. Public Policy Engagement\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/us-public-policy-engagement/overview\" class=\"gilead-corporate-header\">\n   U.S. Public Policy Engagement\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/us-public-policy-engagement/political-contributions-archives\" class=\"gilead-corporate-header\">\n   Political Contributions Archives\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item10 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/supplier-information\" class=\"gilead-corporate-header\">\n   Supplier Information\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/supplier-information/overview\" class=\"gilead-corporate-header\">\n   Supplier Information\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/supplier-information/supplier-enablement-resources-sap-ariba\" class=\"gilead-corporate-header\">\n   Supplier Enablement Resources: SAP Ariba\n</a>\n</div>        </li>\n        <li class=\" level3 item2 odd last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/supplier-information/supplier-inclusion\" class=\"gilead-corporate-header\">\n   Supplier Inclusion\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\" level2 item11 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/annual-impact-reports\" class=\"gilead-corporate-header\">\n   Annual Impact Reports\n</a>\n</div>        </li>\n        <li class=\" level2 item12 odd last rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/company/us-locations\" class=\"gilead-corporate-header\">\n   U.S. Locations\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level1 submenu item5 even last rel-level1\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers\" class=\"gilead-corporate-header\">\n   Careers\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level2 item0 odd first rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/overview\" class=\"gilead-corporate-header\">\n   Careers\n</a>\n</div>        </li>\n        <li class=\"level2 submenu item1 even rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/life-at-gilead\" class=\"gilead-corporate-header\">\n   Life at Gilead\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/life-at-gilead/overview\" class=\"gilead-corporate-header\">\n   Life at Gilead\n</a>\n</div>        </li>\n        <li class=\" level3 item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/life-at-gilead/inclusion-and-diversity-in-hiring\" class=\"gilead-corporate-header\">\n   Inclusion and Diversity in Hiring\n</a>\n</div>        </li>\n</ul>\n        </li>\n        <li class=\"level2 submenu item2 odd rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities\" class=\"gilead-corporate-header\">\n   Opportunities\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level3 item0 odd first rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities/overview\" class=\"gilead-corporate-header\">\n   Opportunities\n</a>\n</div>        </li>\n        <li class=\"level3 submenu item1 even last rel-level3\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities/early-career-opportunities\" class=\"gilead-corporate-header\">\n   Early Career Opportunities\n</a>\n</div>\n<ul class=\"clearfix\" style=\"display: none;\">\n        <li class=\" level4 item0 odd first rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities/early-career-opportunities/overview\" class=\"gilead-corporate-header\">\n   Early Career Opportunities\n</a>\n</div>        </li>\n        <li class=\" level4 item1 even rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities/early-career-opportunities/gilead-internship-program\" class=\"gilead-corporate-header\">\n   Gilead Internship Program\n</a>\n</div>        </li>\n        <li class=\" level4 item2 odd last rel-level4\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/opportunities/early-career-opportunities/postdoctoral-fellowships\" class=\"gilead-corporate-header\">\n   Postdoctoral fellowships\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n        </li>\n        <li class=\" level2 item3 even last rel-level2\">\n<div class=\"navigation-title field-navigationtitle\">\n<a href=\"/careers/global-workforce\" class=\"gilead-corporate-header\">\n   Global Workforce\n</a>\n</div>        </li>\n</ul>\n        </li>\n</ul>\n            </nav>\n        </div>\n    </div>\n\n        </div>\n        <div class=\"col-lg-3 col-xl-3 col-xxl-3 g-sub-navigation\">\n            \n<div class=\"row component column-splitter\">\n        <div class=\"col-xl-12\">\n            \n<div class=\"row component column-splitter\">\n        <div class=\"col-xl-10 g-header-links\">\n            \n\n\n<section class=\"component link-list col-12\">\n  <div class=\"container component-content\">\n    <div class=\"row\">\n\n      <div class=\"col-xl-12\">\n        \n                <ul>\n              <li class=\"item0 odd first\">\n<div class=\"field-link\"><a data-variantfieldname=\"Link\" href=\"/media\" data-variantitemid=\"{4E5B9B1E-6208-433E-9B64-63E61301533B}\" class=\"gilead-corporate-header\">Media</a></div>              </li>\n              <li class=\"item1 even last\">\n<div class=\"field-link\"><a class=\"external-link gilead-corporate-header\" data-variantfieldname=\"Link\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://investors.gilead.com/\" data-variantitemid=\"{69B02304-4718-4EC0-93F7-1548A0986F6D}\">Investors</a></div>              </li>\n        </ul>\n      </div>\n    </div>\n  </div>\n</section>\n\n        </div>\n        <div class=\"col-xl-2 g-header-icons\">\n            <div class=\"component plain-html col-12\">\n<div class=\"field-link country-selector-icon\">\n    <a id=\"country-sel-global-ops\" class=\"gilead-corporate-header\" href=\"/global-operations\">\n        <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 25 25\">\n            <path xmlns=\"http://www.w3.org/2000/svg\" d=\"M12 20C10.9031 20 9.86802 19.7897 8.89475 19.3692C7.92147 18.9487 7.07261 18.3762 6.34817 17.6518C5.62375 16.9274 5.05129 16.0785 4.63078 15.1053C4.21026 14.132 4 13.0969 4 12C4 10.8945 4.21026 9.85722 4.63078 8.88827C5.05129 7.91931 5.62375 7.07261 6.34817 6.34818C7.07261 5.62375 7.92147 5.05129 8.89475 4.63078C9.86802 4.21026 10.9031 4 12 4C13.1055 4 14.1428 4.21026 15.1117 4.63078C16.0807 5.05129 16.9274 5.62375 17.6518 6.34818C18.3762 7.07261 18.9487 7.91931 19.3692 8.88827C19.7897 9.85722 20 10.8945 20 12C20 13.0969 19.7897 14.132 19.3692 15.1053C18.9487 16.0785 18.3762 16.9274 17.6518 17.6518C16.9274 18.3762 16.0807 18.9487 15.1117 19.3692C14.1428 19.7897 13.1055 20 12 20ZM12 18.719C12.4297 18.149 12.7914 17.5741 13.085 16.9943C13.3787 16.4146 13.6178 15.7808 13.8024 15.0931H10.1976C10.393 15.8024 10.6348 16.447 10.9231 17.0267C11.2113 17.6065 11.5703 18.1706 12 18.719ZM10.3693 18.4875C10.0465 18.0243 9.75657 17.4977 9.49961 16.9077C9.24266 16.3177 9.04292 15.7128 8.90041 15.0931H6.04369C6.4885 15.9676 7.085 16.7023 7.83319 17.2972C8.58139 17.8921 9.42674 18.2888 10.3693 18.4875ZM13.6307 18.4875C14.5733 18.2888 15.4186 17.8921 16.1668 17.2972C16.915 16.7023 17.5115 15.9676 17.9563 15.0931H15.0996C14.9301 15.7182 14.7169 16.3258 14.4599 16.9158C14.2029 17.5058 13.9266 18.0297 13.6307 18.4875ZM5.51415 13.83H8.64454C8.59164 13.5169 8.55332 13.21 8.52957 12.9093C8.50582 12.6086 8.49395 12.3055 8.49395 12C8.49395 11.6945 8.50582 11.3914 8.52957 11.0907C8.55332 10.79 8.59164 10.4831 8.64454 10.17H5.51415C5.43318 10.4561 5.37111 10.7536 5.32792 11.0623C5.28473 11.3711 5.26314 11.6837 5.26314 12C5.26314 12.3163 5.28473 12.6289 5.32792 12.9377C5.37111 13.2464 5.43318 13.5439 5.51415 13.83ZM9.90768 13.83H14.0923C14.1452 13.5169 14.1835 13.2127 14.2073 12.9174C14.2311 12.6221 14.2429 12.3163 14.2429 12C14.2429 11.6837 14.2311 11.3779 14.2073 11.0826C14.1835 10.7873 14.1452 10.4831 14.0923 10.17H9.90768C9.85478 10.4831 9.81645 10.7873 9.79269 11.0826C9.76894 11.3779 9.75707 11.6837 9.75707 12C9.75707 12.3163 9.76894 12.6221 9.79269 12.9174C9.81645 13.2127 9.85478 13.5169 9.90768 13.83ZM15.3555 13.83H18.4858C18.5668 13.5439 18.6289 13.2464 18.6721 12.9377C18.7153 12.6289 18.7369 12.3163 18.7369 12C18.7369 11.6837 18.7153 11.3711 18.6721 11.0623C18.6289 10.7536 18.5668 10.4561 18.4858 10.17H15.3555C15.4084 10.4831 15.4467 10.79 15.4704 11.0907C15.4942 11.3914 15.5061 11.6945 15.5061 12C15.5061 12.3055 15.4942 12.6086 15.4704 12.9093C15.4467 13.21 15.4084 13.5169 15.3555 13.83ZM15.0996 8.9069H17.9563C17.5061 8.02159 16.9136 7.28689 16.179 6.70281C15.4443 6.11874 14.5949 5.71928 13.6307 5.50443C13.9535 5.99457 14.2407 6.53061 14.4923 7.11254C14.7438 7.69446 14.9463 8.29258 15.0996 8.9069ZM10.1976 8.9069H13.8024C13.607 8.20298 13.3611 7.55439 13.0648 6.96112C12.7684 6.36787 12.4135 5.80782 12 5.28095C11.5865 5.80782 11.2316 6.36787 10.9352 6.96112C10.6389 7.55439 10.393 8.20298 10.1976 8.9069ZM6.04369 8.9069H8.90041C9.05372 8.29258 9.25615 7.69446 9.50772 7.11254C9.75927 6.53061 10.0465 5.99457 10.3693 5.50443C9.39975 5.71928 8.549 6.12009 7.817 6.70687C7.08501 7.29365 6.49391 8.02699 6.04369 8.9069Z\" fill=\"\"></path>\n        </svg>\n    </a>\n</div></div>\n        </div>\n</div>\n        </div>\n</div>\n        </div>\n</div>\n        </div>\n        <div class=\" col g-header-lang-search\">\n            \n<div class=\"component search-box horizontal col-xl-12 g-header-search-window initialized\" id=\"g-global-search\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/results/&quot;,&quot;suggestionEndpoint&quot;:&quot;//sxa/search/suggestions/&quot;,&quot;suggestionsMode&quot;:&quot;&quot;,&quot;resultPage&quot;:&quot;/search-result&quot;,&quot;targetSignature&quot;:&quot;&quot;,&quot;v&quot;:&quot;{DB79F02C-697A-40CE-A731-9424FB27BEC0}&quot;,&quot;s&quot;:&quot;&quot;,&quot;p&quot;:20,&quot;l&quot;:&quot;en&quot;,&quot;languageSource&quot;:&quot;CurrentLanguage&quot;,&quot;searchResultsSignature&quot;:&quot;&quot;,&quot;itemid&quot;:&quot;{EFC74AF2-1C5C-4D7C-BACD-F20CD4FF35AA}&quot;,&quot;minSuggestionsTriggerCharacterCount&quot;:2}\">\n  <div class=\"component-content d-flex align-items-center\">\n    \n          <label for=\"textBoxSearch\">\n            Search\n          </label>\n        <div class=\"d-flex position-relative\"><span class=\"twitter-typeahead\"><input type=\"text\" class=\"search-box-input tt-hint\" autocomplete=\"off\" maxlength=\"100\" readonly=\"\" spellcheck=\"false\" tabindex=\"-1\" aria-hidden=\"true\" style=\"position: absolute; top: 0px; left: 0px; border-color: transparent; box-shadow: none; opacity: 1; background: none 0% 0% / auto repeat scroll padding-box border-box rgb(255, 255, 255);\" dir=\"ltr\"><input type=\"text\" class=\"search-box-input tt-input\" autocomplete=\"off\" name=\"textBoxSearch\" maxlength=\"100\" placeholder=\"Type a keyword\" spellcheck=\"false\" dir=\"auto\" aria-owns=\"tt-b02864d0-ea5b-e622-dffd-5d0b9aac815e_listbox\" role=\"combobox\" aria-autocomplete=\"list\" aria-expanded=\"false\" style=\"position: relative; vertical-align: top; background-color: transparent;\"><span role=\"status\" aria-live=\"polite\" style=\"position: absolute; padding: 0px; border: 0px; height: 1px; width: 1px; margin-bottom: -1px; margin-right: -1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); white-space: nowrap;\"></span><pre aria-hidden=\"true\" style=\"position: absolute; visibility: hidden; white-space: pre; font-family: proxima-nova, sans-serif; font-size: 24px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;\"></pre><div role=\"listbox\" class=\"tt-menu\" id=\"tt-b02864d0-ea5b-e622-dffd-5d0b9aac815e_listbox\" style=\"position: absolute; top: 100%; left: 0px; z-index: 100; display: none;\"><div role=\"presentation\" class=\"tt-dataset tt-dataset-0\"></div></div></span><button class=\"search-box-button-with-redirect\" type=\"submit\">\n            Search\n          </button></div>\n          \n  </div>\n</div>\n<div class=\"component plain-html col-xl-12 dsk-separator\">\n <div class=\"component-content\">\n<button id=\"btn-search-icon\" class=\"g-search-icon\">\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\">\n                <path d=\"M11 18C14.866 18 18 14.866 18 11C18 7.13401 14.866 4 11 4C7.13401 4 4 7.13401 4 11C4 14.866 7.13401 18 11 18Z\" stroke=\"#464646\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path>\n                <path d=\"M20 20L16 16\" stroke=\"#464646\" stroke-width=\"1.5\" stroke-linecap=\"square\" stroke-linejoin=\"round\"></path>\n        </svg></button>\n<button class=\"g-header-toggle-menu toggle-nav-button\">Hamber</button>\n</div></div>\n        </div>\n</div>    </div>\n</section>\n      </div>\n    </div>\n  </header>\n  <!-- /#header -->\n  <!-- #content -->\n  <main>\n    \n\n\n<section class=\"component breadcrumb breadcrumbs initialized gi-breadcrumb-general-section\">\n\n  <div class=\"container\">\n    <div class=\"row\">\n      <ol class=\"breadcrumbs-list\">\n                  <li class=\"breadcrumbs-list-item field-navigationtitle\"><a href=\"/\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 16 17\"><path d=\"M7.8447 2.5H8.1726C8.51153 2.56504 8.75165 2.7792 8.98637 3.01543C10.4733 4.51005 11.9638 6.00139 13.458 7.48873C13.7042 7.73388 13.9361 7.97997 14.0059 8.33549V8.66353C13.9983 8.68091 13.9878 8.69758 13.9838 8.71566C13.8681 9.24424 13.4507 9.58989 12.9114 9.60281C12.8506 9.60422 12.7898 9.60281 12.7198 9.60281V9.7592C12.7198 10.8955 12.7224 12.0318 12.7189 13.1683C12.7165 13.9495 12.161 14.4981 11.381 14.4985C10.7799 14.499 10.1788 14.4985 9.57763 14.4985C9.2908 14.4985 9.15913 14.3652 9.15889 14.0747C9.15889 13.161 9.1596 12.2471 9.15819 11.3334C9.15772 11.0096 8.93638 10.7555 8.61528 10.7438C8.20616 10.729 7.79564 10.7297 7.38652 10.7454C7.0842 10.7572 6.86404 11.0113 6.85887 11.313C6.85699 11.4262 6.85817 11.5394 6.85817 11.6528C6.85817 12.4728 6.85887 13.2928 6.8577 14.113C6.85746 14.3539 6.71076 14.4985 6.47088 14.4985C5.82681 14.4988 5.18274 14.5025 4.53867 14.4969C3.88943 14.4913 3.30873 13.9296 3.30286 13.2822C3.29183 12.1069 3.2977 10.9314 3.29653 9.75614C3.29653 9.7073 3.29653 9.65869 3.29653 9.60257C3.20992 9.60257 3.14372 9.60539 3.07777 9.6021C2.65246 9.58167 2.33558 9.38067 2.13537 9.00848C1.8983 8.56772 1.99242 8.05934 2.37079 7.68058C3.92159 6.12842 5.47473 4.57862 7.02224 3.02341C7.25977 2.7846 7.5013 2.56622 7.8447 2.5Z\"></path></svg></a></li>\n<li class=\"breadcrumbs-list-item field-navigationtitle\"><a href=\"/science\">Science</a></li><li class=\"breadcrumbs-list-item field-navigationtitle\"><a href=\"/science/pipeline\">Pipeline</a></li>      </ol>\n    </div>\n  </div>\n</section>\n\n\n  <section class=\"component gl-therapeutic-area-filter-values-hidden\">\n<div class=\"container\"><div class=\"row\">\n<div class=\"col-12 col-sm-4\">\n<div class=\"component facet-single-selection-list facet-pipeline-tags col-12 gl-custom-filter-dropdown facet-component initialized\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/facets/&quot;,&quot;f&quot;:&quot;Pipeline Tags&quot;,&quot;showMoreText&quot;:&quot;Show More&quot;,&quot;showLessText&quot;:&quot;Show Less&quot;,&quot;otherText&quot;:&quot;Other&quot;,&quot;collapseOnSelection&quot;:false,&quot;highlightThreshold&quot;:&quot;2&quot;,&quot;highlightBehaviour&quot;:&quot;&quot;,&quot;multi&quot;:true,&quot;emptyValueText&quot;:&quot;[empty]&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;sortOrder&quot;:&quot;SortByNames&quot;}\" id=\"gl-dynamic-ddl-filter-id-1\" style=\"\">\n    <div class=\"component-content\">\n\n\n\n<div class=\"facet-heading\">\n    <h4 class=\"facet-title\">\n        Pipeline Tags\n    </h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Pipeline Tags</label> <label class=\"labelCount\"></label> </button>\n    <span class=\"clear-filter\">x</span>\n</div>\n\n\n\n            <div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><p class=\"facet-value  \" data-facetvalue=\"Advanced%20Cancers\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Advanced Cancers </label></p><p class=\"facet-value  \" data-facetvalue=\"Breast\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Breast </label></p><p class=\"facet-value  \" data-facetvalue=\"Emerging%20Viruses\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Emerging Viruses </label></p><p class=\"facet-value  \" data-facetvalue=\"Fibrotic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Fibrotic Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Gastrointestinal\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gastrointestinal </label></p><p class=\"facet-value  \" data-facetvalue=\"Genitourinary\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Genitourinary </label></p><p class=\"facet-value  \" data-facetvalue=\"Gynecological\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gynecological </label></p><p class=\"facet-value  \" data-facetvalue=\"HBV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HBV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HDV\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HDV </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Prevention\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Prevention </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Treatment\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Treatment </label></p><p class=\"facet-value  \" data-facetvalue=\"Inflammatory%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Inflammatory Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Lung%20and%20Thoracic\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Lung and Thoracic </label></p><p class=\"facet-value  \" data-facetvalue=\"Metabolic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Metabolic Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Other%20Solid%20Tumors\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Other Solid Tumors </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20-%20Oncology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs - Oncology </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20%E2%80%93%20Virology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs \u2013 Virology </label></p></div></div>\n\n\n    <div class=\"bottom-remove-filter\">\n        <button type=\"button\">\nClear All        </button>\n    </div>\n                <div class=\"bottom-filter-button\">\n                    <input type=\"button\" class=\"filterButton\" value=\"Submit\">\n                </div>\n    </div>\n</div>\n\n<div class=\"component facet-single-selection-list facet-oncology-filter therapeutic-area-filter-values facet-component initialized gl-custom-filter-dropdown\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/facets/&quot;,&quot;f&quot;:&quot;Oncology Filter&quot;,&quot;showMoreText&quot;:&quot;Show More&quot;,&quot;showLessText&quot;:&quot;Show Less&quot;,&quot;otherText&quot;:&quot;Other&quot;,&quot;collapseOnSelection&quot;:false,&quot;highlightThreshold&quot;:&quot;2&quot;,&quot;highlightBehaviour&quot;:&quot;&quot;,&quot;multi&quot;:true,&quot;emptyValueText&quot;:&quot;[empty]&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;sortOrder&quot;:&quot;SortByNames&quot;}\" id=\"gl-dynamic-ddl-filter-id-2\" style=\"\">\n    <div class=\"component-content\">\n\n\n\n<div class=\"facet-heading\">\n    <h4 class=\"facet-title\">\n        Oncology\n    </h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Oncology</label> <label class=\"labelCount\"></label> </button>\n    <span class=\"clear-filter\">x</span>\n</div>\n\n\n\n            <div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><p class=\"facet-value  \" data-facetvalue=\"Advanced%20Cancers\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Advanced Cancers </label></p><p class=\"facet-value  \" data-facetvalue=\"Breast\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Breast </label></p><p class=\"facet-value  \" data-facetvalue=\"Gastrointestinal\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gastrointestinal </label></p><p class=\"facet-value  \" data-facetvalue=\"Genitourinary\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Genitourinary </label></p><p class=\"facet-value  \" data-facetvalue=\"Gynecological\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gynecological </label></p><p class=\"facet-value  \" data-facetvalue=\"Lung%20and%20Thoracic\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Lung and Thoracic </label></p><p class=\"facet-value  \" data-facetvalue=\"Other%20Solid%20Tumors\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Other Solid Tumors </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20-%20Oncology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs - Oncology </label></p></div></div>\n\n\n    <div class=\"bottom-remove-filter\">\n        <button type=\"button\">\nClear All        </button>\n    </div>\n                <div class=\"bottom-filter-button\">\n                    <input type=\"button\" class=\"filterButton\" value=\"Filter\">\n                </div>\n    </div>\n</div>\n</div><div class=\"col-12 col-sm-4\">\n<div class=\"component facet-single-selection-list facet-inflammation-filter therapeutic-area-filter-values facet-component initialized gl-custom-filter-dropdown\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/facets/&quot;,&quot;f&quot;:&quot;Inflammation Filter&quot;,&quot;showMoreText&quot;:&quot;Show More&quot;,&quot;showLessText&quot;:&quot;Show Less&quot;,&quot;otherText&quot;:&quot;Other&quot;,&quot;collapseOnSelection&quot;:false,&quot;highlightThreshold&quot;:&quot;2&quot;,&quot;highlightBehaviour&quot;:&quot;&quot;,&quot;multi&quot;:true,&quot;emptyValueText&quot;:&quot;[empty]&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;sortOrder&quot;:&quot;SortByNames&quot;}\" id=\"gl-dynamic-ddl-filter-id-3\" style=\"\">\n    <div class=\"component-content\">\n\n\n\n<div class=\"facet-heading\">\n    <h4 class=\"facet-title\">\n        Inflammation\n    </h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Inflammation</label> <label class=\"labelCount\"></label> </button>\n    <span class=\"clear-filter\">x</span>\n</div>\n\n\n\n            <div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><p class=\"facet-value  \" data-facetvalue=\"Fibrotic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Fibrotic Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Inflammatory%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Inflammatory Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Metabolic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Metabolic Diseases </label></p></div></div>\n\n\n    <div class=\"bottom-remove-filter\">\n        <button type=\"button\">\nClear All        </button>\n    </div>\n                <div class=\"bottom-filter-button\">\n                    <input type=\"button\" class=\"filterButton\" value=\"Filter\">\n                </div>\n    </div>\n</div>\n</div><div class=\"col-12 col-sm-4\">\n<div class=\"component facet-single-selection-list facet-viral-disease-filter therapeutic-area-filter-values facet-component initialized gl-custom-filter-dropdown\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/facets/&quot;,&quot;f&quot;:&quot;Viral Disease Filter&quot;,&quot;showMoreText&quot;:&quot;Show More&quot;,&quot;showLessText&quot;:&quot;Show Less&quot;,&quot;otherText&quot;:&quot;Other&quot;,&quot;collapseOnSelection&quot;:false,&quot;highlightThreshold&quot;:&quot;2&quot;,&quot;highlightBehaviour&quot;:&quot;&quot;,&quot;multi&quot;:true,&quot;emptyValueText&quot;:&quot;[empty]&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;sortOrder&quot;:&quot;SortByNames&quot;}\" id=\"gl-dynamic-ddl-filter-id-4\" style=\"\">\n    <div class=\"component-content\">\n\n\n\n<div class=\"facet-heading\">\n    <h4 class=\"facet-title\">\n        Virology\n    </h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Virology</label> <label class=\"labelCount\"></label> </button>\n    <span class=\"clear-filter\">x</span>\n</div>\n\n\n\n            <div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><p class=\"facet-value  \" data-facetvalue=\"Emerging%20Viruses\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Emerging Viruses </label></p><p class=\"facet-value  \" data-facetvalue=\"HBV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HBV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HDV\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HDV </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Prevention\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Prevention </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Treatment\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Treatment </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20%E2%80%93%20Virology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs \u2013 Virology </label></p></div></div>\n\n\n    <div class=\"bottom-remove-filter\">\n        <button type=\"button\">\nClear All        </button>\n    </div>\n                <div class=\"bottom-filter-button\">\n                    <input type=\"button\" class=\"filterButton\" value=\"Filter\">\n                </div>\n    </div>\n</div>\n</div>\n</div></div>  </section>\n  <section class=\"component herobanner page-banner-single-line-tint\">\n\n<div class=\"container\"><div class=\"row\"><div class=\"banner-text\"><h6 class=\"gl-white field-heading\">PIPELINE</h6><h1 class=\"gl-white field-sub-heading\">Advancing <br>\n<span class=\"gl-forest-green-linear-gradient\">Innovative Therapies</span></h1></div></div></div><div class=\"gl-image-responsive-section w-100\"><img height=\"460\" stylelabs-content-type=\"Image\" alt=\"Three scientists working on a lab\" stylelabs-content-id=\"259038\" width=\"1366\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259038/thumbnail\" src=\"https://gilead.stylelabs.cloud/api/public/content/3d4fc9966e5f412bb3be0976e57fb78f?v=dd8f049a\" data-variantitemid=\"{64717D9B-ACA4-4821-B011-5CA1EAF7C12C}\" format=\"\" data-variantfieldname=\"Image\"><img width=\"375\" height=\"268\" alt=\"pipeline-banner-mobile\" src=\"https://gilead.stylelabs.cloud/api/public/content/1359a5142ad04b32802021f5ee729a53?v=bddb0134\" stylelabs-content-id=\"271155\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/271155/thumbnail\" data-variantitemid=\"{64717D9B-ACA4-4821-B011-5CA1EAF7C12C}\" format=\"\" data-variantfieldname=\"Mobile Image\"></div>  </section>\n      <section class=\"component promo gl-mob-px-8px gl-py-60px gl-bg-primary-blue-red-gradient col-12\">\n       \n<div class=\"container\"><div class=\"row\"><div class=\"col-md-8 col-lg-8 col-xl-8 mx-auto gl-white text-center\"><h6><em>The content in this page is intended only for residents of the United States. The medicines displayed herein may have different labeling in different countries. Please note that not all the medicines are available in all countries.</em></h6></div></div></div>    </section>\n<section class=\"gl-mob-px-8px gl-py-60px\"><div class=\"container\"><div class=\"row\"><div class=\"col-md-10 col-lg-10 col-xl-10 mx-auto text-center\"><h2><span class=\"gl-twilight-sky-linear-gradient\"><strong>Overview</strong></span></h2>\n<p class=\"mb-0\">From long-acting HIV prevention and treatment to promising targets in cancer therapy, we\u2019re discovering, evaluating and advancing investigational compounds that have the potential to transform care for life-threatening diseases. We have a strong and diverse pipeline and are on track to achieve our ambition, set in 2019, of delivering 10+ transformative therapies by 2030. Through pioneering science and innovative partnerships, we\u2019ll continue to expand our research and development programs to take on pressing unmet needs in virology, oncology and inflammation.</p></div></div></div></section>      <section class=\"component Promo With Card gl-mob-px-8px gl-py-60px gl-bg-lefttext-fivecards dynamic-bgimg col-12 responsive-background-image\" data-dsk-bg-img=\"https://gilead.stylelabs.cloud/api/public/content/37a15a44720d4330b9a93d0a523d8d26?v=2adb0a76\" style=\"background-image: url(https://gilead.stylelabs.cloud/api/public/content/37a15a44720d4330b9a93d0a523d8d26?v=2adb0a76); background-size: cover; background-position: center\" data-mob-bg-img=\"https://gilead.stylelabs.cloud/api/public/content/1d5c3e7bea3a4de080e23d6a7f284d9d?v=65d8c277\">\n       \n<div class=\"container\"><div class=\"gl-image-responsive-section-mobile\"><img width=\"1366\" height=\"680\" alt=\"Glance-Pipeline-Desktop\" src=\"https://gilead.stylelabs.cloud/api/public/content/37a15a44720d4330b9a93d0a523d8d26?v=2adb0a76\" stylelabs-content-id=\"259018\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259018/thumbnail\" data-variantitemid=\"{DC5BBE2D-4814-402F-BA56-6C3A125CC5DF}\" format=\"\" data-variantfieldname=\"Image\"><img width=\"375\" height=\"768\" alt=\"Glance-Pipeline-Mobile\" src=\"https://gilead.stylelabs.cloud/api/public/content/1d5c3e7bea3a4de080e23d6a7f284d9d?v=65d8c277\" stylelabs-content-id=\"259153\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259153/thumbnail\" data-variantitemid=\"{DC5BBE2D-4814-402F-BA56-6C3A125CC5DF}\" format=\"\" data-variantfieldname=\"Image2\"></div><div class=\"img-media-desktop\"></div><div class=\"row\"><div class=\"col-md-4 col-lg-4 col-xl-4 \">\n\t<h2 class=\"gl-white headline\"> Gilead Pipeline at a Glance </h2>\n\t<p class=\"gl-white\"> Updated: October 30, 2025, data as of end of Q3 </p>\n\t<div class=\"gl-white italic-14px\"> ** Program count does not include potential partner opt-in programs or publicly announced planned programs. </div>\n</div>\n\n<div class=\"col-md-5 col-lg-5 col-xl-5 col-12 \">\n<div class=\"card left\">\n  <div class=\"card-body\">\n\t<div class=\"title-84\"> 56 </div>\n\t<h5> Clinical stage programs** </h5>\n  </div>\n</div>\n</div>\n\n\n\n<div class=\"col-md-3 col-lg-3 col-xl-3 col-6 \">\n<div class=\"card \">\n  <div class=\"card-body\">\n\t<div class=\"title-84\"> 7 </div>\n\t<h5> Opt-in Programs </h5>\n  </div>\n</div>\n</div>\n\n\n\n<div class=\"col-md-3 col-lg-3 col-xl-3 col-6 offset-md-3\">\n<div class=\"card \">\n  <div class=\"card-body\">\n\t<div class=\"title-84\"> 24 </div>\n\t<h5> <span class=\"gl-navigate-phase\">Phase 1</span> </h5>\n  </div>\n</div>\n</div>\n\n\n\n<div class=\"col-md-3 col-lg-3 col-xl-3 col-6 \">\n<div class=\"card \">\n  <div class=\"card-body\">\n\t<div class=\"title-84\"> 15 </div>\n\t<h5> <span class=\"gl-navigate-phase\">Phase 2</span> </h5>\n  </div>\n</div>\n</div>\n\n\n\n<div class=\"col-md-3 col-lg-3 col-xl-3 col-6 \">\n<div class=\"card \">\n  <div class=\"card-body\">\n\t<div class=\"title-84\"> 16 </div>\n\t<h5> <span class=\"gl-navigate-phase\">Phase 3</span> </h5>\n  </div>\n</div>\n</div>\n\n</div></div>    </section>\n  <section class=\"component gl-therapeutic-area-filter gl-py-60px\">\n<div class=\"container\"><div class=\"row\"><div class=\"col-md-12 col-lg-12 col-xl-12\"><div class=\"row\"><div class=\"col-md-5 col-lg-5 col-xl-5 gl-pipeline-name\">Pipeline</div><div class=\"col-md-7 col-lg-7 col-xl-7 pipeline-disclaimer\"></div></div><div class=\"gl-border-bottom\"></div></div></div><div class=\"row gl-news-filter-landing-section\"><div class=\"col-md-7 col-lg-7 col-xl-7 gl-filter-modal\" id=\"gl-news-modal-popup\"><div><div class=\"gl-filter-mob-head\"><span>Filters</span> <button type=\"button\" class=\"btn-popup-close\">\n                             <span class=\"gl-close-button\">\u00d7</span>\n                        </button></div></div><div class=\"row gl-filter-values\"><div class=\"col-md-7 col-lg-7 col-xl-7\"><div class=\"component facet-pipeline-therapeutic-areas gl-custom-filter-dropdown gl-filter-dropdown-group\" id=\"gl-dynamic-ddl-filter-id-5\"><div class=\"component-content\"><div class=\"facet-heading\"><h4 class=\"facet-title\">Therapeutic Areas</h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Therapeutic Areas</label> <label class=\"labelCount\"></label> </button></div><div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><span class=\"gl-filter-category-name\">Oncology</span><div class=\"gl-filter-category-area Oncology\" filter-id=\"gl-dynamic-ddl-filter-id-2\" data-attribute=\"Oncology\"><p class=\"facet-value  \" data-facetvalue=\"Advanced%20Cancers\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Advanced Cancers </label></p><p class=\"facet-value  \" data-facetvalue=\"Breast\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Breast </label></p><p class=\"facet-value  \" data-facetvalue=\"Gastrointestinal\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gastrointestinal </label></p><p class=\"facet-value  \" data-facetvalue=\"Genitourinary\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Genitourinary </label></p><p class=\"facet-value  \" data-facetvalue=\"Gynecological\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Gynecological </label></p><p class=\"facet-value  \" data-facetvalue=\"Lung%20and%20Thoracic\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Lung and Thoracic </label></p><p class=\"facet-value  \" data-facetvalue=\"Other%20Solid%20Tumors\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Other Solid Tumors </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20-%20Oncology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs - Oncology </label></p></div><span class=\"gl-filter-category-name\">Inflammation</span><div class=\"gl-filter-category-area Inflammation\" filter-id=\"gl-dynamic-ddl-filter-id-3\" data-attribute=\"Inflammation\"><p class=\"facet-value  \" data-facetvalue=\"Fibrotic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Fibrotic Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Inflammatory%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Inflammatory Diseases </label></p><p class=\"facet-value  \" data-facetvalue=\"Metabolic%20Diseases\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Metabolic Diseases </label></p></div><span class=\"gl-filter-category-name\">Virology</span><div class=\"gl-filter-category-area Virology\" filter-id=\"gl-dynamic-ddl-filter-id-4\" data-attribute=\"Virology\"><p class=\"facet-value  \" data-facetvalue=\"Emerging%20Viruses\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Emerging Viruses </label></p><p class=\"facet-value  \" data-facetvalue=\"HBV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HBV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HDV\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HDV </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Cure\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Cure </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Prevention\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Prevention </label></p><p class=\"facet-value  \" data-facetvalue=\"HIV%20Treatment\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">HIV Treatment </label></p><p class=\"facet-value  \" data-facetvalue=\"Potential%20Opt-in%20Programs%20%E2%80%93%20Virology\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Potential Opt-in Programs \u2013 Virology </label></p></div></div></div></div></div></div><div class=\"col-md-5 col-lg-5 col-xl-5\">\n<div class=\"component facet-single-selection-list facet-pipeline-trial-phase gl-custom-filter-dropdown facet-component initialized\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/facets/&quot;,&quot;f&quot;:&quot;Pipeline Trial Phase&quot;,&quot;showMoreText&quot;:&quot;Show More&quot;,&quot;showLessText&quot;:&quot;Show Less&quot;,&quot;otherText&quot;:&quot;Other&quot;,&quot;collapseOnSelection&quot;:false,&quot;highlightThreshold&quot;:&quot;2&quot;,&quot;highlightBehaviour&quot;:&quot;&quot;,&quot;multi&quot;:true,&quot;emptyValueText&quot;:&quot;[empty]&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;sortOrder&quot;:&quot;&quot;}\" id=\"gl-dynamic-ddl-filter-id-6\" style=\"\">\n    <div class=\"component-content\">\n\n\n\n<div class=\"facet-heading\">\n    <h4 class=\"facet-title\">\n        Trial Phase\n    </h4><button class=\"gl-dropdown-label\"><label class=\"labelText\">Trial Phase</label> <label class=\"labelCount\"></label> </button>\n    <span class=\"clear-filter\">x</span>\n</div>\n\n\n\n            <div class=\"contentContainer\"><div class=\"facet-search-filter facet-hided\"><p class=\"facet-value  \" data-facetvalue=\"Filed\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Filed </label></p><p class=\"facet-value  \" data-facetvalue=\"Opt-in%20Trials\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Opt-in Trials </label></p><p class=\"facet-value  \" data-facetvalue=\"Phase%201\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Phase 1 </label></p><p class=\"facet-value  \" data-facetvalue=\"Phase%202\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Phase 2 </label></p><p class=\"facet-value  \" data-facetvalue=\"Phase%203\"><input type=\"checkbox\" name=\"facetValue\"><label for=\"facetName\">Phase 3 </label></p></div></div>\n\n\n    <div class=\"bottom-remove-filter\">\n        <button type=\"button\">\nClear All        </button>\n    </div>\n                <div class=\"bottom-filter-button\">\n                    <input type=\"button\" class=\"filterButton\" value=\"Filter\">\n                </div>\n    </div>\n</div>\n</div></div><div class=\"row\"><div class=\"gl-filter-mob-buttons text-center\"><button class=\"btn  g-btn-secondary\" role=\"button\">\n                                <span> Reset </span>\n                            </button>\n                            <button class=\"btn g-btn-primary\" role=\"button\">\n                                Apply Filter\n                            </button></div></div></div><div class=\"col-md-5 col-lg-5 col-xl-5\"><div class=\"gl-search-box gl-responsive-filter gl-search-suggestion-box\">\n<div class=\"component search-box horizontal initialized\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/results/&quot;,&quot;suggestionEndpoint&quot;:&quot;//sxa/search/suggestions/&quot;,&quot;suggestionsMode&quot;:&quot;ShowSearchResultsAsPredictions&quot;,&quot;resultPage&quot;:&quot;&quot;,&quot;targetSignature&quot;:&quot;&quot;,&quot;v&quot;:&quot;{961F5EBC-9A20-442B-8234-6EFD6DAFE4EB}&quot;,&quot;s&quot;:&quot;{B5AA5689-719C-4965-8E20-4B67741FF639}&quot;,&quot;p&quot;:5,&quot;l&quot;:&quot;&quot;,&quot;languageSource&quot;:&quot;SearchResultsLanguage&quot;,&quot;searchResultsSignature&quot;:&quot;pipeline&quot;,&quot;itemid&quot;:&quot;{EFC74AF2-1C5C-4D7C-BACD-F20CD4FF35AA}&quot;,&quot;minSuggestionsTriggerCharacterCount&quot;:2}\">\n  <div class=\"component-content d-flex align-items-center\">\n    \n        <span class=\"twitter-typeahead\"><input type=\"text\" class=\"search-box-input tt-hint\" autocomplete=\"off\" maxlength=\"100\" readonly=\"\" spellcheck=\"false\" tabindex=\"-1\" aria-hidden=\"true\" style=\"position: absolute; top: 0px; left: 0px; border-color: transparent; box-shadow: none; opacity: 1; background: none 0% 0% / auto repeat scroll padding-box border-box rgb(255, 255, 255);\" dir=\"ltr\"><input type=\"text\" class=\"search-box-input tt-input\" autocomplete=\"off\" name=\"textBoxSearch\" maxlength=\"100\" placeholder=\"Search our Pipeline\" spellcheck=\"false\" dir=\"auto\" aria-owns=\"tt-625f8a4e-c36f-8e77-fd91-8cb9673baeb3_listbox\" role=\"combobox\" aria-autocomplete=\"list\" aria-expanded=\"false\" style=\"position: relative; vertical-align: top; background-color: transparent;\"><button class=\"filtericon\" type=\"button\"><svg xmlns=\"http://www.w3.org/2000/svg\" width=\"18\" height=\"20\" viewBox=\"0 0 18 20\" fill=\"none\"><path d=\"M9 3h8M1 17h3M1 3h4m3 14h9m-3-7h3M1 10h9M5 3a2 2 0 1 0 4 0 2 2 0 0 0-4 0zM10 10a2 2 0 1 0 4 0 2 2 0 0 0-4 0zM4 17a2 2 0 1 0 4 0 2 2 0 0 0-4 0z\" stroke=\"#464646\" stroke-linecap=\"round\"></path></svg></button><span class=\"removeClick\"><svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M4.898 20 4 19.102 11.102 12 4 4.898 4.898 4 12 11.102 19.102 4l.898.898L12.898 12 20 19.102l-.898.898L12 12.898 4.898 20z\" fill=\"#6D6D6D\"></path></svg></span><span class=\"searchicon\"><svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M11 18C14.866 18 18 14.866 18 11C18 7.13401 14.866 4 11 4C7.13401 4 4 7.13401 4 11C4 14.866 7.13401 18 11 18Z\" stroke=\"#464646\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path><path d=\"M20 20L16 16\" stroke=\"#464646\" stroke-width=\"1.5\" stroke-linecap=\"square\" stroke-linejoin=\"round\"></path></svg></span><span role=\"status\" aria-live=\"polite\" style=\"position: absolute; padding: 0px; border: 0px; height: 1px; width: 1px; margin-bottom: -1px; margin-right: -1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); white-space: nowrap;\"></span><pre aria-hidden=\"true\" style=\"position: absolute; visibility: hidden; white-space: pre; font-family: proxima-nova, sans-serif; font-size: 18px; font-style: normal; font-variant: normal; font-weight: 500; word-spacing: 0px; letter-spacing: 0.18px; text-indent: 0px; text-rendering: auto; text-transform: none;\"></pre><div role=\"listbox\" class=\"tt-menu\" id=\"tt-625f8a4e-c36f-8e77-fd91-8cb9673baeb3_listbox\" style=\"position: absolute; top: 100%; left: 0px; z-index: 100; display: none;\"><div role=\"presentation\" class=\"tt-dataset tt-dataset-1\"></div></div></span>\n          <button class=\"search-box-button\" type=\"submit\">\n            Search\n          </button>\n  </div>\n</div>\n</div></div></div><div class=\"row\"><div class=\"col-md-12 col-lg-12 col-xl-12\"><div class=\"gl-border-bottom\"></div></div></div><div class=\"row\"><div class=\"component plain-html gl-news_map_section stories_piller_map_section\" style=\"display: none;\"><div class=\"row\"><div class=\"gl-filter-map-section col-md-10 col-xl-10\" data-filter-map=\"filter-dropdown-stories-categories\" style=\"display: none;\"></div></div></div><div class=\"col-md-12 col-lg-12 col-xl-12\"><div class=\"gl-border-bottom\"></div></div></div></div>  </section>\n  <section class=\"component gl-therapeutic-area-filter-results  sort-by-tagorder\">\n<div class=\"container\">\n\n\n  <div class=\"component search-results initialized\" data-class-variant=\"\" data-properties=\"{&quot;endpoint&quot;:&quot;//sxa/search/results/&quot;,&quot;v&quot;:&quot;{16E72BF3-7230-403E-BB34-EAE20C26BD0F}&quot;,&quot;s&quot;:&quot;{B5AA5689-719C-4965-8E20-4B67741FF639}&quot;,&quot;l&quot;:&quot;en&quot;,&quot;p&quot;:100,&quot;defaultSortOrder&quot;:&quot;Pipeline Therapeutic Areas,Descending&quot;,&quot;sig&quot;:&quot;pipeline&quot;,&quot;itemid&quot;:&quot;{EFC74AF2-1C5C-4D7C-BACD-F20CD4FF35AA}&quot;,&quot;autoFireSearch&quot;:true}\"><ul class=\"search-result-list\"> <li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Cure\" data-order=\"6\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-category-header-image dynamic-bgimg\" style=\"background-image: url(https://gilead.stylelabs.cloud/api/public/content/2e89ab5571c04c5684909d6c40871229?v=2b0d4d00); background-size: cover; background-position: center\"><div class=\"gl-image-responsive-section\"><img width=\"1200\" height=\"232\" alt=\"Pipeline-Search-Virology-Desktop\" src=\"https://gilead.stylelabs.cloud/api/public/content/2e89ab5571c04c5684909d6c40871229?v=2b0d4d00\" stylelabs-content-id=\"259049\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259049/thumbnail\" data-variantitemid=\"{04242D6D-DC27-43DF-A54C-37C4EED17334}\" format=\"\" data-variantfieldname=\"Image\"><img width=\"335\" height=\"377\" alt=\"Pipeline-Search-Virology-Mobile\" src=\"https://gilead.stylelabs.cloud/api/public/content/45ab3fcd2cbf4595a349c1392a254f7d?v=c83afe9b\" stylelabs-content-id=\"259150\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259150/thumbnail\" data-variantitemid=\"{04242D6D-DC27-43DF-A54C-37C4EED17334}\" format=\"\" data-variantfieldname=\"ImageMobile\"></div><div class=\"field-header-info\"><div class=\"row\"><div class=\"category-name col-md-4 col-xl-3 field-therapeuticareaname\">Virology</div><div class=\"category-description col-md-6 col-xl-4 field-therapeuticareadescription\">We're building on our legacy in virology, developing long-acting options for HIV prevention and treatment, new treatments for chronic hepatitis B and D and preparing for emerging viruses.</div></div></div></div><div class=\"pipeline-sub-category-section HIV Cure\" data-attribute=\"HIV Cure\"><div class=\"field-sub-category-name\" data-attribute=\"HIV Cure\"><div class=\"sub-category-name field-tagname\">HIV Cure</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Teropavimab + zinlirvimab</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Non-Gilead sponsored trial(s) ongoing.</p>\n<p class=\"fs-12\">Teropavimab and zinlirvimab are broadly neutralizing antibodies (bNAbs).</p>\n<p class=\"fs-12\">Breakthrough Therapy Designation</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Cure\" data-order=\"8\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Cure\" data-attribute=\"HIV Cure\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Vesatolimod (FRESH)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Cure\" data-order=\"9\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Cure\" data-attribute=\"HIV Cure\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV bispecific T-cell engager (GS-8588)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Prevention\" data-order=\"1\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Prevention\" data-attribute=\"HIV Prevention\"><div class=\"field-sub-category-name\" data-attribute=\"HIV Prevention\"><div class=\"sub-category-name field-tagname\">HIV Prevention</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Yeztugo\u00ae (PURPOSE 1 &amp; 2)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV pre-exposure prophylaxis (PrEP) long-acting injectable</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap filed\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Filed</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">NDA approved and EC approved</p>\n<p class=\"fs-12\">Breakthrough Therapy Designation</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Prevention\" data-order=\"2\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Prevention\" data-attribute=\"HIV Prevention\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Lenacapavir (PURPOSE 365)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV pre-exposure prophylaxis (PrEP) long-acting injectable</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"2\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"field-sub-category-name\" data-attribute=\"HIV Treatment\"><div class=\"sub-category-name field-tagname\">HIV Treatment</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Bictegravir/lenacapavir oral combination (ARTISTRY-1 &amp; ARTISTRY-2)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Oral for virologically suppressed treatment-experienced and virologically suppressed people living with HIV</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"4\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Islatravir/lenacapavir oral combination (ISLEND-1 &amp; ISLEND-2)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting oral for virologically suppressed people living with HIV</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Subject to Gilead and Merck co-development and co-commercialization agreement.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"5\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Lenacapavir + teropavimab + zinlirvimab</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting injectable for virologically suppressed people living with HIV</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Teropavimab and zinlirvimab are broadly neutralizing antibodies (bNAbs).</p>\n<p class=\"fs-12\">Breakthrough Therapy Designation</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"8\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV INSTI/capsid inhibitor (GS-1720/GS-4182) (WONDERS-1 &amp; -2)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting oral</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">INSTI \u2013 Integrase strand transfer inhibitor</p>\n<p class=\"fs-12\">Program timelines pending resolution of GS-1720 and GS-4182 clinical holds.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"9\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV capsid inhibitor (GS-3107)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting oral</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"10\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV INSTI (GS-1219)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting injectable</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\">INSTI \u2013 Integrase strand transfer inhibitor</div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"11\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV INSTI (GS-3242)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting injectable</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\">INSTI \u2013 Integrase strand transfer inhibitor</div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HIV Treatment\" data-order=\"13\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HIV Treatment\" data-attribute=\"HIV Treatment\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HIV NRTTI (GS-1614)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Long-acting injectable</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Subject to Gilead and Merck co-development and co-commercialization agreement.&nbsp;</p> <p class=\"fs-12\">NRTTI - nucleoside reverse transcriptase translocation inhibitor</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"Emerging Viruses\" data-order=\"1\" data-tag-order=\"4\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section Emerging Viruses\" data-attribute=\"Emerging Viruses\"><div class=\"field-sub-category-name\" data-attribute=\"Emerging Viruses\"><div class=\"sub-category-name field-tagname\">Emerging Viruses</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Obeldesivir\u00ae</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Respiratory syncytial virus</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"Emerging Viruses\" data-order=\"2\" data-tag-order=\"4\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section Emerging Viruses\" data-attribute=\"Emerging Viruses\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Obeldesivir\u00ae</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Pediatric respiratory syncytial virus</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HBV Cure\" data-order=\"1\" data-tag-order=\"5\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HBV Cure\" data-attribute=\"HBV Cure\"><div class=\"field-sub-category-name\" data-attribute=\"HBV Cure\"><div class=\"sub-category-name field-tagname\">HBV Cure</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Selgantolimod</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HBV cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HBV Cure\" data-order=\"2\" data-tag-order=\"5\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HBV Cure\" data-attribute=\"HBV Cure\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HBV therapeutic vaccine (GS-2829 + GS-6779)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HBV cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HDV\" data-order=\"1\" data-tag-order=\"6\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HDV\" data-attribute=\"HDV\"><div class=\"field-sub-category-name\" data-attribute=\"HDV\"><div class=\"sub-category-name field-tagname\">HDV</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Hepcludex\u00ae (MYR301)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HDV</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap filed\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Filed</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Full Marketing Authorization by the European Medicines Agency (EMA) for the treatment of adults with chronic HDV and compensated liver disease.</p>\n<p class=\"fs-12\">Biologics License Application (BLA) pending with U.S. Food &amp; Drug Administration (FDA).</p>\n<p class=\"fs-12\">Breakthrough Therapy and PRIME designations.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"HDV\" data-order=\"2\" data-tag-order=\"6\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section HDV\" data-attribute=\"HDV\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">HDV pre-S1 nAb (GS-4321)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HDV</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"Potential Opt-in Programs \u2013 Virology\" data-order=\"1\" data-tag-order=\"7\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section Potential Opt-in Programs \u2013 Virology\" data-attribute=\"Potential Opt-in Programs \u2013 Virology\"><div class=\"field-sub-category-name\" data-attribute=\"Potential Opt-in Programs \u2013 Virology\"><div class=\"sub-category-name field-tagname\">Potential Opt-in Programs \u2013 Virology</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Assembly Biosciences</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HBV, HDV, herpes simplex virus (HSV)</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap opt-in-trials\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">4 CLINICAL STAGE PROGRAMS</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper green-theme\" data-category=\"Virology\" data-tag=\"Potential Opt-in Programs \u2013 Virology\" data-order=\"3\" data-tag-order=\"7\"><div class=\"pipeline-wrapper Virology\" data-attribute=\"Virology\"><div class=\"pipeline-sub-category-section Potential Opt-in Programs \u2013 Virology\" data-attribute=\"Potential Opt-in Programs \u2013 Virology\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Hookipa</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HIV Cure</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap opt-in-trials\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">1 CLINICAL STAGE PROGRAM</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-category-header-image dynamic-bgimg\" style=\"background-image: url(https://gilead.stylelabs.cloud/api/public/content/6de0e2b1751444e1ade96b257e92be2a?v=507cb8ab); background-size: cover; background-position: center\"><div class=\"gl-image-responsive-section\"><img width=\"1200\" height=\"232\" alt=\"Pipeline-Search-Oncology-Desktop\" src=\"https://gilead.stylelabs.cloud/api/public/content/6de0e2b1751444e1ade96b257e92be2a?v=507cb8ab\" stylelabs-content-id=\"259033\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259033/thumbnail\" data-variantitemid=\"{A46FB538-F2C0-4BE3-A459-7EB6109B967C}\" format=\"\" data-variantfieldname=\"Image\"><img width=\"335\" height=\"353\" alt=\"Pipeline-Search-Oncology-Mobile\" src=\"https://gilead.stylelabs.cloud/api/public/content/ec01b727606e47dcaa2915d06e2e4880?v=07b92327\" stylelabs-content-id=\"259146\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259146/thumbnail\" data-variantitemid=\"{A46FB538-F2C0-4BE3-A459-7EB6109B967C}\" format=\"\" data-variantfieldname=\"ImageMobile\"></div><div class=\"field-header-info\"><div class=\"row\"><div class=\"category-name col-md-4 col-xl-3 field-therapeuticareaname\">Oncology</div><div class=\"category-description col-md-6 col-xl-4 field-therapeuticareadescription\">We are advancing a world-class oncology portfolio that includes some of the most promising targets in cancer treatment today.</div></div></div></div><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"field-sub-category-name\" data-attribute=\"Advanced Cancers\"><div class=\"sub-category-name field-tagname\">Advanced Cancers</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">GS-5319</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"1\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Denikitug (GS-1811)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"2\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">DGK\u03b1  inhibitor (GS-9911)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"3\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">GS-2121</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"4\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">IL-2 Variant (GS-4528)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"5\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">IL-18BP (GS-0321)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\">Operationalized by Compugen</div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"6\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Masked IL-12 (XTX301)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Operationalized by Xilio</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"7\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">MCL1 inhibitor (GS-9716)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Advanced Cancers\" data-order=\"8\" data-tag-order=\"0\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Advanced Cancers\" data-attribute=\"Advanced Cancers\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">PARP1 inhibitor (GS-0201)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Breast\" data-order=\"1\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Breast\" data-attribute=\"Breast\"><div class=\"field-sub-category-name\" data-attribute=\"Breast\"><div class=\"sub-category-name field-tagname\">Breast</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy (ASCENT-03)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic triple-negative breast cancer (PD-L1-)</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">sBLA submitted</p>\n<p class=\"fs-12\">PD-L1 \u2013 programmed death-ligand 1 </p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Breast\" data-order=\"2\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Breast\" data-attribute=\"Breast\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy + pembrolizumab (ASCENT-04)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic triple-negative breast cancer (PD-L1+)</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">sBLA submitted</p>\n<p class=\"fs-12\">In collaboration with Merck.</p>\n<p class=\"fs-12\">PD-L1 \u2013 programmed death-ligand 1 </p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Breast\" data-order=\"3\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Breast\" data-attribute=\"Breast\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy + pembrolizumab (ASCENT-05)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\"><span style=\"color: #212121;\">High risk adjuvant triple-negative breast cancer</span></div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Breast\" data-order=\"4\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Breast\" data-attribute=\"Breast\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy (ASCENT-07)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">HR+/HER2- chemo-na\u00efve metastatic breast cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">HR+/HER2 \u2013 Hormone receptor positive, human epidermal growth factor receptor 2 negative </p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"1\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"field-sub-category-name\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"sub-category-name field-tagname\">Cell Therapy: Lymphoma</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Axicabtagene ciloleucel (ZUMA-22)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">2L+ high-risk follicular lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"2\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Axicabtagene ciloleucel (ZUMA-23)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L high-risk large B-cell lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"5\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Brexucabtagene autoleucel (ZUMA-4)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Pediatric acute lymphocytic leukemia/ non-Hodgkin lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"6\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">CD19/CD20 bicistronic (KITE-363)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Relapsed/refractory diffuse large B-cell lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">CD 19 and 20 are B-lymphocyte antigens. CD \u2013 cluster of differentiation</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"7\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">CD19/CD20 bicistronic (KITE-753)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Relapsed/refractory diffuse large B-cell lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Manufacturing innovation.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Lymphoma\" data-order=\"8\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Lymphoma\" data-attribute=\"Cell Therapy: Lymphoma\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">CD19 CAR (KITE-197)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Relapsed/refractory diffuse large B-cell lymphoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Manufacturing innovation.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Multiple Myeloma\" data-order=\"3\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Multiple Myeloma\" data-attribute=\"Cell Therapy: Multiple Myeloma\"><div class=\"field-sub-category-name\" data-attribute=\"Cell Therapy: Multiple Myeloma\"><div class=\"sub-category-name field-tagname\">Cell Therapy: Multiple Myeloma</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Anitocabtagene autoleucel (iMMagine-3)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\"><span data-teams=\"true\">2-4L relapsed/refractory multiple myeloma</span></div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\">Global strategic collaboration to co-develop and co-commercialize with Arcellx.</div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Multiple Myeloma\" data-order=\"4\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Multiple Myeloma\" data-attribute=\"Cell Therapy: Multiple Myeloma\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Anitocabtagene autoleucel (iMMagine-1)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">4L+ relapsed/refractory multiple myeloma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Global strategic collaboration to co-develop and co-commercialize with Arcellx.&nbsp;</p> <p class=\"fs-12\"> </p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Cell Therapy: Autoimmune Diseases\" data-order=\"1\" data-tag-order=\"4\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Cell Therapy: Autoimmune Diseases\" data-attribute=\"Cell Therapy: Autoimmune Diseases\"><div class=\"field-sub-category-name\" data-attribute=\"Cell Therapy: Autoimmune Diseases\"><div class=\"sub-category-name field-tagname\">Cell Therapy: Autoimmune Diseases</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">CD19/CD20 bicistronic (KITE-363)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Rheumatology</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Gastrointestinal\" data-order=\"1\" data-tag-order=\"5\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Gastrointestinal\" data-attribute=\"Gastrointestinal\"><div class=\"field-sub-category-name\" data-attribute=\"Gastrointestinal\"><div class=\"sub-category-name field-tagname\">Gastrointestinal</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Domvanalimab + zimberelimab + chemotherapy (STAR-221)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L upper gastrointestinal cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Arcus Biosciences.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Gastrointestinal\" data-order=\"2\" data-tag-order=\"5\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Gastrointestinal\" data-attribute=\"Gastrointestinal\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Etrumadenant + zimberelimab combinations (ARC-9)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Metastatic colorectal cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Arcus Biosciences.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Gastrointestinal\" data-order=\"3\" data-tag-order=\"5\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Gastrointestinal\" data-attribute=\"Gastrointestinal\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Quemliclustat +/- zimberelimab (ARC-8)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Metastatic pancreatic ductal adenocarcinoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Arcus Biosciences.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Genitourinary\" data-order=\"2\" data-tag-order=\"6\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Genitourinary\" data-attribute=\"Genitourinary\"><div class=\"field-sub-category-name\" data-attribute=\"Genitourinary\"><div class=\"sub-category-name field-tagname\">Genitourinary</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy + combinations (TROPHY U-01)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic urothelial carcinoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Gynecological\" data-order=\"1\" data-tag-order=\"7\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Gynecological\" data-attribute=\"Gynecological\"><div class=\"field-sub-category-name\" data-attribute=\"Gynecological\"><div class=\"sub-category-name field-tagname\">Gynecological</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy (ASCENT-GYN-01)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">2L metastatic endometrial cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\">In collaboration with the GOG Foundation (GOG) and European Network of Gynecological Oncological Trial Groups (ENGOT).</div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"1\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"field-sub-category-name\" data-attribute=\"Lung and Thoracic\"><div class=\"sub-category-name field-tagname\">Lung and Thoracic</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy + pembrolizumab (EVOKE-03)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic non-small cell lung cancer (PD-L1+, TPS<span style=\"text-decoration: underline;\">&gt;</span>50%)</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Merck. </p> <p class=\"fs-12\">PD-L1 \u2013 Programmed death-ligand 1 </p> <p class=\"fs-12\">TPS \u2013 tumor proportion scale</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"2\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Domvanalimab + zimberelimab + chemotherapy (STAR-121)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic non-small cell lung cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Arcus Biosciences.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"3\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy (EVOKE-SCLC-04)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Extensive stage - small cell lung cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-3\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 3</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"4\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy + pembrolizumab (EVOKE-02)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L metastatic non-small cell lung cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">In collaboration with Merck.</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"4\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Lung cancer platform (VELOCITY-Lung, EDGE-Lung)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Non-small cell lung cancer</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">VELOCITY-Lung includes combinations of domvanalimab, etrumadenant, zimberelimab, and sacituzumab govitecan-hziy.</p> <p class=\"fs-12\">EDGE-Lung, in collaboration with Arcus Biosciences, includes immunotherapy-based combinations of quemliclustat, domvanalimab, and zimberelimab</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Lung and Thoracic\" data-order=\"5\" data-tag-order=\"8\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Lung and Thoracic\" data-attribute=\"Lung and Thoracic\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Domvanalimab + zimberelimab + chemo (VELOCITY-HNSCC)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">1L head and neck squamous cell carcinoma</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><span style=\"color: #7f7f7f; letter-spacing: 0pt;\">In collaboration with Arcus Biosciences.</span></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Other Solid Tumors\" data-order=\"1\" data-tag-order=\"9\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Other Solid Tumors\" data-attribute=\"Other Solid Tumors\"><div class=\"field-sub-category-name\" data-attribute=\"Other Solid Tumors\"><div class=\"sub-category-name field-tagname\">Other Solid Tumors</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Sacituzumab govitecan-hziy (TROPiCS-03)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Basket (Solid tumors)</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Potential Opt-in Programs - Oncology\" data-order=\"2\" data-tag-order=\"10\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Potential Opt-in Programs - Oncology\" data-attribute=\"Potential Opt-in Programs - Oncology\"><div class=\"field-sub-category-name\" data-attribute=\"Potential Opt-in Programs - Oncology\"><div class=\"sub-category-name field-tagname\">Potential Opt-in Programs - Oncology</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Arcus</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap opt-in-trials\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">2 CLINICAL STAGE PROGRAMS</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper blue-theme\" data-category=\"Oncology\" data-tag=\"Potential Opt-in Programs - Oncology\" data-order=\"4\" data-tag-order=\"10\"><div class=\"pipeline-wrapper Oncology\" data-attribute=\"Oncology\"><div class=\"pipeline-sub-category-section Potential Opt-in Programs - Oncology\" data-attribute=\"Potential Opt-in Programs - Oncology\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">MacroGenics</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Advanced cancers</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap opt-in-trials\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">1 CLINICAL STAGE PROGRAM</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Fibrotic Diseases\" data-order=\"1\" data-tag-order=\"1\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-category-header-image dynamic-bgimg\" style=\"background-image: url(https://gilead.stylelabs.cloud/api/public/content/582fea49ae244d3392dfecebd163a61f?v=a6a0b734); background-size: cover; background-position: center\"><div class=\"gl-image-responsive-section\"><img width=\"1200\" height=\"232\" alt=\"Pipeline-Search-Inflammation-Desktop\" src=\"https://gilead.stylelabs.cloud/api/public/content/582fea49ae244d3392dfecebd163a61f?v=a6a0b734\" stylelabs-content-id=\"259024\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259024/thumbnail\" data-variantitemid=\"{9566E68B-D619-4EA6-96B3-0B343AF4ED32}\" format=\"\" data-variantfieldname=\"Image\"><img width=\"335\" height=\"353\" alt=\"Pipeline-Search-Inflammation-Mobile\" src=\"https://gilead.stylelabs.cloud/api/public/content/44137deccb0c472a8cbccb54083f4ff7?v=6e750b8b\" stylelabs-content-id=\"259148\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259148/thumbnail\" data-variantitemid=\"{9566E68B-D619-4EA6-96B3-0B343AF4ED32}\" format=\"\" data-variantfieldname=\"ImageMobile\"></div><div class=\"field-header-info\"><div class=\"row\"><div class=\"category-name col-md-4 col-xl-3 field-therapeuticareaname\">Inflammation</div><div class=\"category-description col-md-6 col-xl-4 field-therapeuticareadescription\">We are advancing new treatments to help address the needs of people living with inflammatory and fibrotic diseases, including primary biliary cholangitis (PBC), inflammatory bowel disease, lupus and metabolic dysfunction-associated steatohepatitis (NASH).</div></div></div></div><div class=\"pipeline-sub-category-section Fibrotic Diseases\" data-attribute=\"Fibrotic Diseases\"><div class=\"field-sub-category-name\" data-attribute=\"Fibrotic Diseases\"><div class=\"sub-category-name field-tagname\">Fibrotic Diseases</div></div><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Cilofexor / firsocostat / semaglutide combination (WAYFIND)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Nonalcoholic steatohepatitis</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">Clinical collaboration with Novo Nordisk. </p> <p class=\"fs-12\"> </p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"2\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"field-sub-category-name\" data-attribute=\"Inflammatory Diseases\"><div class=\"sub-category-name field-tagname\">Inflammatory Diseases</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Edecesertib (COSMIC)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Lupus</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"3\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">Tilpisertib fosmecarbil (PALEKONA)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory bowel disease</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"4\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">FXR agonist (GS-8670)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory Bowel Disease</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"4\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">\u03b14\u03b27 inhibitor (SWIFT)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory Bowel Disease</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-2\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 2</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"5\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row row-clickable\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">BTLA agonist (GS-0272)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory diseases</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"><div class=\"field-action\"></div></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"><div class=\"field-notestitle\">Notes</div><div class=\"field-notesdetail\"><p class=\"fs-12\">BTLA - B- and T-lymphocyte attenuator</p></div></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"5\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">CD200R agonist (GS-5305)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory Diseases</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"6\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">PD1 agonist (GS-0151)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory Diseases</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Inflammatory Diseases\" data-order=\"8\" data-tag-order=\"2\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Inflammatory Diseases\" data-attribute=\"Inflammatory Diseases\"><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">IRAK4 Degrader (GS-6791)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Inflammatory diseases</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li><li class=\"list-pipeline-wrapper red-theme\" data-category=\"Inflammation\" data-tag=\"Metabolic Diseases\" data-order=\"1\" data-tag-order=\"3\"><div class=\"pipeline-wrapper Inflammation\" data-attribute=\"Inflammation\"><div class=\"pipeline-sub-category-section Metabolic Diseases\" data-attribute=\"Metabolic Diseases\"><div class=\"field-sub-category-name\" data-attribute=\"Metabolic Diseases\"><div class=\"sub-category-name field-tagname\">Metabolic Diseases</div></div><div class=\"pipeline-list-content\"><div class=\"row\"><div class=\"col-md-7 col-xl-7\"><div class=\"col-md-12\"><div class=\"field-headbrandname\">GLP-1R Agonist (GS-4571)</div></div><div class=\"col-md-12\"><div class=\"field-potentialindication\">Metabolic Disease</div></div></div><div class=\"col-md-4 col-xl-4\"><div class=\"phase-info\"><div class=\"phase-wrap phase-1\"><div class=\"phase phase1\"><span class=\"arrow\"></span></div><div class=\"phase phase2\"><span class=\"arrow\"></span></div><div class=\"phase phase3\"><span class=\"arrow\"></span></div></div><div class=\"phase-name field-tagname\">Phase 1</div></div></div><div class=\"col-md-1 col-xl-1\"></div></div><div class=\"row\"><div class=\" col-md-12 col-xl-12 section-details\"><div class=\"section-notes\"></div><div class=\"section-extra-info\"></div></div></div></div></div></div></li></ul><div class=\"search-result-overlay\"></div></div>\n\n</div>  </section>\n      <section class=\"component cards gl-tab-accordion gl-bg-margin-accordion-cards\">\n       \n<div class=\"container\"><div class=\"col-md-12 col-xl-12\"><h2 style=\"text-align: center;\">Understanding&nbsp; Pipeline Terms</h2><div class=\"tabs_wrapper\"><div class=\"row\"><div class=\"col-md-4 col-xl-4\">\n    <ul class=\"tabs initialized\">\n        \n        \n                \n                <li class=\"active\" rel=\"tab-Phase1\">Phase 1</li>\n                        \n                \n                           \n                 \n        \n                \n                <li rel=\"tab-Phase2\">Phase 2</li>\n                            \n                 \n        \n                \n                <li rel=\"tab-Phase3\">Phase 3</li>\n                            \n                 \n        \n                \n                <li rel=\"tab-Opt-intrials\">Opt-in Programs</li>\n                            \n                 \n        \n\n    </ul>\n</div>\n<div class=\"col-md-8 col-xl-8\">\n        <div class=\"tab_container\" style=\"min-height: 339px;\">\n        \n            \n                    \n                    <h6 class=\"d_active tab_drawer_heading\" rel=\"tab-Phase1\">Phase 1</h6>\n                    <div class=\"d_active tab_content\" id=\"tab-Phase1\" style=\"display: block;\"><h2>Phase 1</h2>\n<p class=\"mb-0\">Phase 1 clinical trials test an investigational therapy in humans for the first time, with a focus on safety. Participants can be healthy or have been diagnosed with a specific condition.</p></div>    \n                    \n                               \n                    \n                    \n            \n                    \n                    <h6 class=\"tab_drawer_heading\" rel=\"tab-Phase2\">Phase 2</h6>\n                    <div id=\"tab-Phase2\" class=\"tab_content\" style=\"display: none;\"><h2>Phase 2</h2>\n<p class=\"mb-0\">Phase 2 clinical trials study efficacy while also collecting data about safety. Participants have been diagnosed with a specific condition that is being studied.</p></div> \n                               \n                    \n                    \n            \n                    \n                    <h6 class=\"tab_drawer_heading\" rel=\"tab-Phase3\">Phase 3</h6>\n                    <div id=\"tab-Phase3\" class=\"tab_content\" style=\"display: none;\"><h2><strong>Phase 3</strong></h2>\n<p class=\"mb-0\">Phase 3 clinical trials involve a larger group of patients and study the efficacy of the investigational therapy in comparison to other approved or experimental therapies. The study is designed to gather information for the investigational therapy to be used in a specific population.</p></div> \n                               \n                    \n                    \n            \n                    \n                    <h6 class=\"tab_drawer_heading\" rel=\"tab-Opt-intrials\">Opt-in Programs</h6>\n                    <div id=\"tab-Opt-intrials\" class=\"tab_content\" style=\"display: none;\"><h2>Opt-in Programs</h2>\n<p class=\"mb-0\">At Gilead, an opt-in program is an existing program of a Gilead or Kite partner to which Gilead or Kite has an \u201copt-in\u201d right to participate in the future development and/or commercialization of the program. The specific terms of the opt-in right and future participation are governed by collaboration, option or similar agreements.</p></div> \n                               \n                    \n                    \n            \n        </div>\n</div></div></div></div></div>    </section>\n      <section class=\"component cards gl-three-card-img-btm-text gl-bg-nuetral-grey-100\">\n       \n<div class=\"container\"><div class=\"row\"><div class=\"col-md-12 col-lg-12 col-xl-12\"></div>\n<div class=\"col-md-4 col-lg-4 col-xl-4\">\n<div class=\"card \">\n<div class=\"gl-image-responsive-section\">\n<img width=\"384\" height=\"360\" alt=\"Clinical-trial\" src=\"https://gilead.stylelabs.cloud/api/public/content/03aaaa67bcf44c92bb360c392d43994c?v=0feb200d\" stylelabs-content-id=\"299148\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/299148/thumbnail\" format=\"\">\n</div>\n<div class=\"card-body\">\n<h4>Clinical Trials</h4>\n<p class=\"three-line\">We're committed to involving the communities most impacted by disease in the design and execution of our clinical trials.</p>\n<br>\n<div class=\"gl-card-button\">\n<a class=\"External-Icon\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://www.gileadclinicaltrials.com/\">\nLearn More\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\">\n<path d=\"M16.109 13.266v3.153c0 .182.009.368-.015.549l.025-.179c-.02.13-.055.256-.105.378l.069-.164a1.598 1.598 0 0 1-.194.332l.108-.141a1.608 1.608 0 0 1-.269.27l.143-.11a1.6 1.6 0 0 1-.35.206l.174-.072a1.594 1.594 0 0 1-.401.107l.185-.024c-.163.02-.33.012-.495.012h-7.46c-.17 0-.342.008-.51-.014l.179.024a1.597 1.597 0 0 1-.38-.104l.164.068a1.606 1.606 0 0 1-.332-.193l.141.108a1.612 1.612 0 0 1-.272-.268l.111.142A1.59 1.59 0 0 1 6.42 17l.072.172a1.579 1.579 0 0 1-.108-.4l.024.186c-.02-.163-.012-.33-.012-.494V9.03c0-.168-.007-.34.015-.507l-.025.178c.02-.13.054-.256.105-.378l-.069.164c.051-.118.116-.229.194-.332l-.108.142a1.61 1.61 0 0 1 .269-.272l-.143.11a1.6 1.6 0 0 1 .349-.204l-.173.071c.13-.053.263-.089.4-.107l-.185.024c.269-.032.55-.012.819-.012h2.843c.38 0 .7-.31.703-.69a.703.703 0 0 0-.692-.7H7.338c-.193 0-.38.015-.573.049a2.13 2.13 0 0 0-.636.237 2.134 2.134 0 0 0-.523.409A2.28 2.28 0 0 0 5 8.793V16.697c0 .154.018.303.039.456.03.224.12.442.22.643.097.196.241.377.395.532.427.431 1.02.646 1.622.646h7.933a2.764 2.764 0 0 0 .652-.076c.139-.037.274-.097.405-.155.201-.09.384-.231.546-.378.322-.292.56-.72.642-1.146a2.97 2.97 0 0 0 .05-.563v-3.378a.703.703 0 0 0-.693-.7.703.703 0 0 0-.702.69zM12.753 6.417l1.735.001 2.912.003h.898c.38 0 .7-.31.703-.69a.703.703 0 0 0-.693-.7h-1.734l-2.912-.003-.899-.001c-.38 0-.7.31-.702.69-.003.376.312.7.692.7z\" fill=\"#C5203F\"></path>\n<path d=\"M18.995 11.25a9945.808 9945.808 0 0 0 .004-4.628v-.895a.704.704 0 0 0-.692-.7.703.703 0 0 0-.702.69 9950.759 9950.759 0 0 1-.005 5.523c0 .379.31.697.692.7a.703.703 0 0 0 .703-.69z\" fill=\"#C5203F\"></path>\n<path d=\"M10.956 14.011a4795.027 4795.027 0 0 0 2.457-2.445L15.57 9.42l1.963-1.954 1.161-1.155.104-.104a.7.7 0 0 0-.005-.982.707.707 0 0 0-.987.005l-.716.712-1.74 1.733-2.157 2.146-1.964 1.954-1.16 1.155-.104.104a.7.7 0 0 0 .005.982.707.707 0 0 0 .986-.005z\" fill=\"#C5203F\"></path>\n</svg>\n\n</a>\n</div>\n</div>\n</div>\n</div>\n\n<div class=\"col-md-4 col-lg-4 col-xl-4\">\n<div class=\"card \">\n<div class=\"gl-image-responsive-section\">\n<img height=\"360\" class=\"card-img-top rounded-0\" stylelabs-content-type=\"Image\" alt=\"Cards-Our-Medicines-Pipeline-Desktop\" stylelabs-content-id=\"259012\" width=\"384\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259012/thumbnail\" src=\"https://gilead.stylelabs.cloud/api/public/content/d46560dc285f4388bc4d7d75342014b7?v=ac845029\" format=\"\">\n</div>\n<div class=\"card-body\">\n<h4>Medicines</h4>\n<p class=\"three-line\">We currently offer more than 25 therapies in the U.S. and are rapidly growing our portfolio through research and development, as well as collaborations.</p>\n<div class=\"gl-card-button\">\n<a href=\"/medicines\">\nLearn More\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\">\n<path d=\"M6 12H18\" stroke=\"#C5203F\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path>\n<path d=\"M12 6L18 12L12 18\" stroke=\"#C5203F\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path>\n</svg>\n\n</a>\n</div>\n</div>\n</div>\n</div>\n\n<div class=\"col-md-4 col-lg-4 col-xl-4\">\n<div class=\"card \">\n<div class=\"gl-image-responsive-section\">\n<img width=\"384\" height=\"360\" alt=\"Cards-ClinicalTrial-Pipeline-Desktop\" src=\"https://gilead.stylelabs.cloud/api/public/content/79ce375e04d8415da56b1c864d525416?v=fb59c3e6\" stylelabs-content-id=\"259015\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/259015/thumbnail\" format=\"\">\n</div>\n<div class=\"card-body\">\n<h4>Research</h4>\n<p class=\"three-line\">We aim to continuously bring new therapies into clinical development and are propelled by our passion to save the lives of people around the world.</p>\n<div class=\"gl-card-button\">\n<a href=\"/science/research\">\nLearn More\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\">\n<path d=\"M6 12H18\" stroke=\"#C5203F\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path>\n<path d=\"M12 6L18 12L12 18\" stroke=\"#C5203F\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"></path>\n</svg>\n\n</a>\n</div>\n</div>\n</div>\n</div>\n\n</div></div>    </section>\n\n\n  </main>\n  <!-- /#content -->\n  <!-- #footer -->\n  <footer class=\"gl-footer\">\n    <div class=\"container\">\n      <div class=\"row\">\n        \n\n\n\n\n<div class=\"col-lg-3 mb-md-5\">\n  <div class=\"gl-logo\">\n    <img width=\"168\" height=\"45\" alt=\"All-Pages-Gilead-logo\" src=\"https://gilead.stylelabs.cloud/api/public/content/89749f3b535e4eebb8ae07c8e9607b17?v=bf06f14e\" stylelabs-content-id=\"267124\" stylelabs-content-type=\"Image\" thumbnailsrc=\"https://gilead.stylelabs.cloud/api/gateway/267124/thumbnail\">\n    <p class=\"logo-description\"> This is our global website, intended for visitors seeking information on Gilead\u2019s worldwide business. Some content on this site is not intended for people outside the United States. Visit our <a class=\"g-footer-global-ops gilead-corporate-footer\" href=\"/global-operations\">Global Operations</a>&nbsp;page for links to our international corporate websites.</p>\n  </div>\n  <ul class=\"social-media-list\">\n          <li class=\"social-media-list-item\">\n            <a href=\"https://twitter.com/GileadSciences\" target=\"_blank\" class=\"gilead-corporate-footer\">\n\n              <i class=\"fa fa fanew-x\" aria-hidden=\"true\"></i>\n            </a>\n          </li>\n          <li class=\"social-media-list-item\">\n            <a href=\"https://www.linkedin.com/company/gilead-sciences/\" target=\"_blank\" class=\"gilead-corporate-footer\">\n\n              <i class=\"fa fa fa-linkedin-square\" aria-hidden=\"true\"></i>\n            </a>\n          </li>\n          <li class=\"social-media-list-item\">\n            <a href=\"https://www.instagram.com/gileadsciences/\" target=\"_blank\" class=\"gilead-corporate-footer\">\n\n              <i class=\"fa fa fa-instagram\" aria-hidden=\"true\"></i>\n            </a>\n          </li>\n          <li class=\"social-media-list-item\">\n            <a href=\"https://www.facebook.com/GileadSciences\" target=\"_blank\" class=\"gilead-corporate-footer\">\n\n              <i class=\"fa fa fanew-facebook\" aria-hidden=\"true\"></i>\n            </a>\n          </li>\n          <li class=\"social-media-list-item\">\n            <a href=\"https://www.youtube.com/channel/UCNSt7PtsfNGbezR9hmvRI1w\" target=\"_blank\" class=\"gilead-corporate-footer\">\n\n              <i class=\"fa fa fa-youtube-play\" aria-hidden=\"true\"></i>\n            </a>\n          </li>\n\n  </ul>\n</div>\n\n<div class=\"col-md-4 col-lg-2 offset-lg-1\">\n  <h3>QUICK LINKS</h3>\n  <ul class=\"list\">\n          <li class=\"list-item \">\n            <a class=\"external-link gilead-corporate-footer\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://investors.gilead.com/overview/default.aspx\">Investors</a>\n          </li>\n          <li class=\"list-item \">\n            <a class=\"external-link gilead-corporate-footer\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://www.gileadclinicaltrials.com\">Find a Trial</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/science/pipeline\" class=\"gilead-corporate-footer\">Pipeline</a>\n          </li>\n          <li class=\"list-item \">\n            <a class=\"external-link gilead-corporate-footer\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://gilead.yello.co/job_boards/v42vD4vKxb3AkKvV93YsrQ\">Search for Jobs</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/news\" class=\"gilead-corporate-footer\">News</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/stories\" class=\"gilead-corporate-footer\">Stories@Gilead</a>\n          </li>\n\n  </ul>\n</div>\n<div class=\"col-md-4 col-lg-3\">\n  <h3>GET IN TOUCH</h3>\n  <ul class=\"list\">\n          <li class=\"list-item \">\n            <a href=\"/contact-us\" class=\"gilead-corporate-footer\">Contact Us</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/contact-us/report-an-adverse-event\" class=\"gilead-corporate-footer\">Report an Adverse Event</a>\n          </li>\n          <li class=\"list-item \">\n            <a class=\"external-link gilead-corporate-footer\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https://www.askgileadmedical.com\">Medical Information</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/contact-us/partnership-request\" class=\"gilead-corporate-footer\">Partnership Request</a>\n          </li>\n\n  </ul>\n</div>\n<div class=\"col-md-4 col-lg-3\">\n  <h3>LEGAL</h3>\n  <ul class=\"list\">\n          <li class=\"list-item \">\n            <a target=\"_blank\" rel=\"noopener noreferrer\" href=\"/-/media/files/pdfs/footer/modern-slavery-statement.pdf\" class=\"gilead-corporate-footer\">Modern Slavery Act Statement</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/company/us-public-policy-engagement\" class=\"gilead-corporate-footer\">Public Policy Engagement</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/social-media-guidelines\" class=\"gilead-corporate-footer\">Social Media Guidelines</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/privacy-statements\" class=\"gilead-corporate-footer\">Privacy Statement</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/privacy-statements/consumer-health-data-privacy-policy\" class=\"gilead-corporate-footer\">Consumer Health Data Privacy Policy</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/terms-of-use\" class=\"gilead-corporate-footer\">Terms of Use</a>\n          </li>\n          <li class=\"list-item \">\n            <a href=\"/cookie-statement\" class=\"gilead-corporate-footer\">Cookie Statement</a>\n          </li>\n\n  </ul>\n</div>\n<hr>\n<div class=\"copyright\">\n  <p>\n    \u00a9 1996-2025 Gilead Sciences, Inc. All rights reserved.\n        <span class=\"g-footer-global-ops\">\n          <a href=\"/global-operations\" class=\"gilead-corporate-footer\">\n            <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 25 25\"><path xmlns=\"http://www.w3.org/2000/svg\" d=\"M12 20C10.9031 20 9.86802 19.7897 8.89475 19.3692C7.92147 18.9487 7.07261 18.3762 6.34817 17.6518C5.62375 16.9274 5.05129 16.0785 4.63078 15.1053C4.21026 14.132 4 13.0969 4 12C4 10.8945 4.21026 9.85722 4.63078 8.88827C5.05129 7.91931 5.62375 7.07261 6.34817 6.34818C7.07261 5.62375 7.92147 5.05129 8.89475 4.63078C9.86802 4.21026 10.9031 4 12 4C13.1055 4 14.1428 4.21026 15.1117 4.63078C16.0807 5.05129 16.9274 5.62375 17.6518 6.34818C18.3762 7.07261 18.9487 7.91931 19.3692 8.88827C19.7897 9.85722 20 10.8945 20 12C20 13.0969 19.7897 14.132 19.3692 15.1053C18.9487 16.0785 18.3762 16.9274 17.6518 17.6518C16.9274 18.3762 16.0807 18.9487 15.1117 19.3692C14.1428 19.7897 13.1055 20 12 20ZM12 18.719C12.4297 18.149 12.7914 17.5741 13.085 16.9943C13.3787 16.4146 13.6178 15.7808 13.8024 15.0931H10.1976C10.393 15.8024 10.6348 16.447 10.9231 17.0267C11.2113 17.6065 11.5703 18.1706 12 18.719ZM10.3693 18.4875C10.0465 18.0243 9.75657 17.4977 9.49961 16.9077C9.24266 16.3177 9.04292 15.7128 8.90041 15.0931H6.04369C6.4885 15.9676 7.085 16.7023 7.83319 17.2972C8.58139 17.8921 9.42674 18.2888 10.3693 18.4875ZM13.6307 18.4875C14.5733 18.2888 15.4186 17.8921 16.1668 17.2972C16.915 16.7023 17.5115 15.9676 17.9563 15.0931H15.0996C14.9301 15.7182 14.7169 16.3258 14.4599 16.9158C14.2029 17.5058 13.9266 18.0297 13.6307 18.4875ZM5.51415 13.83H8.64454C8.59164 13.5169 8.55332 13.21 8.52957 12.9093C8.50582 12.6086 8.49395 12.3055 8.49395 12C8.49395 11.6945 8.50582 11.3914 8.52957 11.0907C8.55332 10.79 8.59164 10.4831 8.64454 10.17H5.51415C5.43318 10.4561 5.37111 10.7536 5.32792 11.0623C5.28473 11.3711 5.26314 11.6837 5.26314 12C5.26314 12.3163 5.28473 12.6289 5.32792 12.9377C5.37111 13.2464 5.43318 13.5439 5.51415 13.83ZM9.90768 13.83H14.0923C14.1452 13.5169 14.1835 13.2127 14.2073 12.9174C14.2311 12.6221 14.2429 12.3163 14.2429 12C14.2429 11.6837 14.2311 11.3779 14.2073 11.0826C14.1835 10.7873 14.1452 10.4831 14.0923 10.17H9.90768C9.85478 10.4831 9.81645 10.7873 9.79269 11.0826C9.76894 11.3779 9.75707 11.6837 9.75707 12C9.75707 12.3163 9.76894 12.6221 9.79269 12.9174C9.81645 13.2127 9.85478 13.5169 9.90768 13.83ZM15.3555 13.83H18.4858C18.5668 13.5439 18.6289 13.2464 18.6721 12.9377C18.7153 12.6289 18.7369 12.3163 18.7369 12C18.7369 11.6837 18.7153 11.3711 18.6721 11.0623C18.6289 10.7536 18.5668 10.4561 18.4858 10.17H15.3555C15.4084 10.4831 15.4467 10.79 15.4704 11.0907C15.4942 11.3914 15.5061 11.6945 15.5061 12C15.5061 12.3055 15.4942 12.6086 15.4704 12.9093C15.4467 13.21 15.4084 13.5169 15.3555 13.83ZM15.0996 8.9069H17.9563C17.5061 8.02159 16.9136 7.28689 16.179 6.70281C15.4443 6.11874 14.5949 5.71928 13.6307 5.50443C13.9535 5.99457 14.2407 6.53061 14.4923 7.11254C14.7438 7.69446 14.9463 8.29258 15.0996 8.9069ZM10.1976 8.9069H13.8024C13.607 8.20298 13.3611 7.55439 13.0648 6.96112C12.7684 6.36787 12.4135 5.80782 12 5.28095C11.5865 5.80782 11.2316 6.36787 10.9352 6.96112C10.6389 7.55439 10.393 8.20298 10.1976 8.9069ZM6.04369 8.9069H8.90041C9.05372 8.29258 9.25615 7.69446 9.50772 7.11254C9.75927 6.53061 10.0465 5.99457 10.3693 5.50443C9.39975 5.71928 8.549 6.12009 7.817 6.70687C7.08501 7.29365 6.49391 8.02699 6.04369 8.9069Z\" fill=\"#464646\"></path></svg>\n\n            Global Operations\n          </a>\n        </span>\n\n    <span> <a href=\"/sitemap\" class=\"gilead-corporate-footer\">Sitemap</a> </span>\n  </p>\n</div>\n\n      </div>\n    </div>\n  </footer>\n  <!-- /#footer -->\n</div>\n<!-- /#wrapper -->\n\n    \n\n\n\n\n\n\n\n<script src=\"/-/media/base-themes/core-libraries/scripts/ie-origin-fix.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/xaquery.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/moment.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/lo-dash.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/modernizr.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/galleria-161.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/fullcalendar.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/gcal.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/jqueryuitouch-punchmin.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/hammer.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/backbone-min.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/typeahead.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/mediaelement-and-player.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/dailymotion.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/facebook.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/soundcloud.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/twitch.js\"></script><script src=\"/-/media/base-themes/core-libraries/scripts/vimeo.js\"></script><script src=\"/-/media/base-themes/xa-api/scripts/xa.js\"></script><script src=\"/-/media/base-themes/gilead-main-theme/scripts/observer.js\"></script><script src=\"/-/media/base-themes/gilead-main-theme/scripts/partial-design-highlight.js\"></script><script src=\"/-/media/base-themes/google-maps-js-connector/scripts/google-maps-connector.js\"></script><script src=\"/-/media/base-themes/maps/scripts/component-location-service.js\"></script><script src=\"/-/media/base-themes/maps/scripts/component-map.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-location-service.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-ajax.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-base-model.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-base-view.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-box.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-data.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-summary.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-dropdown.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-managed-range.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-range-slider.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-slider.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-load-more.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-location-filter.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-page-selector.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-page-size.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-parameters.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-query.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-radius-filter.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-results.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-results-count.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-results-filter.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-sort.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-url.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-variant-filter.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-service.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-router.js\"></script><script src=\"/-/media/base-themes/gilead-search-theme/scripts/component-search-facet-daterange.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/accessibility.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-accordions.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-archive.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-breadcrumb.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-carousel.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-container.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-disqus.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-facebook.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-flip.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-fullcalendar.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-galleria.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-language-selector.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-navigation.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-overlay.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-snippet.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-social.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-tabs.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-toggle.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-video.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/component-video-playlist.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/details-polyfill.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/fixheight.js\"></script><script src=\"/-/media/base-themes/components-theme/scripts/search-fixheight.js\"></script><script src=\"/-/media/base-themes/resolve-conflicts/scripts/resolveconflicts.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/jquery-371min.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/bootstrapbundlemin.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/gilead-pre-optimized.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/owlcarousel.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/svgpanzoommin.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/global-map.js\"></script><script src=\"/-/media/themes/gilead/gileadcorporate/gileaddefault/scripts/jquerymatchheightmin.js\"></script>    <!-- /#wrapper -->\n\n<script type=\"text/javascript\" id=\"\" charset=\"\">(function(h){function f(a){switch(a.type){case \"timeupdate\":b[a.target.id].current=Math.round(a.target.currentTime);var d=Math.floor(100*b[a.target.id].current/a.target.duration),c;for(c in b[a.target.id]._progress_markers)d>=c&&c>b[a.target.id].greatest_marker&&(b[a.target.id].greatest_marker=c);b[a.target.id].greatest_marker&&!b[a.target.id]._progress_markers[b[a.target.id].greatest_marker]&&(b[a.target.id]._progress_markers[b[a.target.id].greatest_marker]=!0,dataLayer.push({event:\"gaEvent\",gaEventCategory:\"Videos\",\ngaEventAction:\"Completion_\"+b[a.target.id].greatest_marker+\"%\",gaEventLabel:decodeURIComponent(a.target.currentSrc.split(\"/\")[a.target.currentSrc.split(\"/\").length-1])}));break;case \"play\":void 0===b[a.target.id].hasPlayed?(b[a.target.id].hasPlayed=!0,dataLayer.push({event:\"gaEvent\",gaEventCategory:\"Videos\",gaEventAction:\"Play\",gaEventLabel:decodeURIComponent(a.target.currentSrc.split(\"/\")[a.target.currentSrc.split(\"/\").length-1])})):dataLayer.push({event:\"gaEvent\",gaEventCategory:\"Videos\",gaEventAction:\"Unpause\",\ngaEventLabel:decodeURIComponent(a.target.currentSrc.split(\"/\")[a.target.currentSrc.split(\"/\").length-1])});break;case \"pause\":dataLayer.push({event:\"gaEvent\",gaEventCategory:\"Videos\",gaEventAction:\"Pause\",gaEventLabel:decodeURIComponent(a.target.currentSrc.split(\"/\")[a.target.currentSrc.split(\"/\").length-1]),gaEventValue:b[a.target.id].current});break;case \"ended\":dataLayer.push({event:\"gaEvent\",gaEventCategory:\"Videos\",gaEventAction:\"Finished\",gaEventLabel:decodeURIComponent(a.target.currentSrc.split(\"/\")[a.target.currentSrc.split(\"/\").length-\n1])})}}for(var g=25,b={},c=document.getElementsByTagName(\"video\"),d=0;d<c.length;d++){if(c[d].getAttribute(\"id\"))var e=c[d].getAttribute(\"id\");else e=\"html5_video_\"+Math.random().toString(36).slice(2),c[d].setAttribute(\"id\",e);b[e]={};b[e].greatest_marker=0;b[e]._progress_markers={};for(j=0;100>j;j++)b[e].progress_point=g*Math.floor(j/g),b[e]._progress_markers[b[e].progress_point]=!1;b[e].current=0;c[d].addEventListener(\"play\",f,!1);c[d].addEventListener(\"pause\",f,!1);c[d].addEventListener(\"ended\",\nf,!1);c[d].addEventListener(\"timeupdate\",f,!1);c[d].addEventListener(\"ended\",f,!1)}h.videoEventHandler=f})(window);</script><div style=\"display: none; visibility: hidden;\">    \n    <script src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\" type=\"text/javascript\" charset=\"UTF-8\" data-domain-script=\"ca7369fb-0f82-4ffa-90d3-0694f620d948\"></script>\n    <script type=\"text/javascript\">function OptanonWrapper(){};</script>\n    \n</div><script type=\"text/javascript\" id=\"\" charset=\"\">(function(a){a:{a=a.location.search.substring(1);a=a.split(\"\\x26\");for(var b=0;b<a.length;b++){var c=a[b].split(\"\\x3d\");if(\"gid\"==c[0]){a=c[1];break a}}a=!1}a&&dataLayer.push({gid:a})})(window);</script><script type=\"text/javascript\" id=\"\" charset=\"\">for(var btnInfoElements=document.querySelectorAll(\".add_to_cart_button\"),i=0;i<btnInfoElements.length;i++)btnInfoElements[i].addEventListener(\"mouseover\",function(){var a=this,c=setTimeout(function(){var b=a.textContent.trim();dataLayer.push({event:\"hover\",element:\"Button\",elementText:b})},3E3);a.addEventListener(\"mouseout\",function(){clearTimeout(c)})});</script><iframe height=\"0\" width=\"0\" style=\"display: none; visibility: hidden;\" data-gtm-yt-inspected-1003614_477=\"true\" data-gtm-yt-inspected-1003614_481=\"true\" data-gtm-yt-inspected-1003614_482=\"true\" data-gtm-yt-inspected-1003614_483=\"true\" data-gtm-yt-inspected-1003614_485=\"true\" data-gtm-yt-inspected-1003614_631=\"true\" data-gtm-yt-inspected-1003614_1178=\"true\" data-gtm-yt-inspected-1003614_748=\"true\" data-gtm-yt-inspected-1003614_1084=\"true\" data-gtm-yt-inspected-552=\"true\"></iframe><script type=\"text/javascript\" id=\"\" charset=\"\">(function(e){function g(a,d,b){a.addEventListener?a.addEventListener(d,b):a.attachEvent&&a.attachEvent(\"on\"+d,b)}function f(){for(var a=0,d=e.length;a<d;a++){var b=document.documentElement;b=self.pageYOffset||b&&b.scrollTop||document.body.scrollTop;var c=document.documentElement;c=self.innerHeight||c&&c.clientHeight||document.body.clientHeight;b=(b+c)/document.body.scrollHeight*100;c=e[a]+\"%\";0>h.indexOf(c)&&b>e[a]&&(h.push(c),dataLayer.push({event:\"gild.event\",eventCategory:\"Pages\",eventAction:\"Reached \"+\nc,eventLabel:document.title,eventNonInteraction:!0}))}}var h=[];\"complete\"===document.readyState?f():g(window,\"load\",f);g(window,\"scroll\",f)})([20,40,60,80,100]);</script><iframe height=\"0\" width=\"0\" src=\"https://3471255.fls.doubleclick.net/activityi;src=3471255;type=corpo0;cat=gc_na001;ord=1;num=3408157523899;npa=0;auiddc=576778687.1762541755;uaa=;uab=64;uafvl=Chromium%3B140.0.7339.208%7CNot%253DA%253FBrand%3B24.0.0.0%7CGoogle%2520Chrome%3B140.0.7339.208;uamb=0;uam=;uap=Windows;uapv=15.0.0;uaw=0;pscdl=noapi;frm=0;_tu=KJA;gtm=45fe5b50v9190713287z871003614za200zb71003614zd71003614xea;gcd=13l3l3l3l1l1;dma=0;dc_fmt=2;tag_exp=101509157~103116026~103200004~103233427~104527907~104528501~104684208~104684211~104948813~115480709~115583767~115616986~115938466~115938468~116217636~116217638;epver=2;dc_random=1762541756_LlytpQlxUNHO4R3KVsv0gfXGWVOycoXh9Q;_dc_test=1;~oref=https%3A%2F%2Fwww.gilead.com%2Fscience%2Fpipeline?\" style=\"display: none; visibility: hidden;\" data-gtm-yt-inspected-1003614_477=\"true\" data-gtm-yt-inspected-1003614_481=\"true\" data-gtm-yt-inspected-1003614_482=\"true\" data-gtm-yt-inspected-1003614_483=\"true\" data-gtm-yt-inspected-1003614_485=\"true\" data-gtm-yt-inspected-1003614_631=\"true\" data-gtm-yt-inspected-1003614_1178=\"true\" data-gtm-yt-inspected-1003614_748=\"true\" data-gtm-yt-inspected-1003614_1084=\"true\" data-gtm-yt-inspected-552=\"true\"></iframe><div id=\"onetrust-consent-sdk\" data-nosnippet=\"true\"><div class=\"onetrust-pc-dark-filter ot-fade-in\" style=\"z-index:2147483645;\"></div><div id=\"onetrust-banner-sdk\" class=\"otFlat bottom ot-wo-title\" tabindex=\"0\" role=\"region\" aria-label=\"Cookie banner\" style=\"bottom: 0px;\"><div role=\"dialog\" aria-modal=\"true\" aria-label=\"Privacy\"><div class=\"ot-sdk-container\"><div class=\"ot-sdk-row\"><div id=\"onetrust-group-container\" class=\"ot-sdk-eight ot-sdk-columns\"><div class=\"banner_logo\"></div><div id=\"onetrust-policy\"><div id=\"onetrust-policy-text\">We may utilize tracking technologies such as cookies and pixels to process personal data in order to enhance your experience on our site and to analyze performance and traffic. You may exercise your consumer right to opt-out by clicking the \u201cCookies Settings\u201d link. For further information about the data we may collect, please see our<a class=\"ot-cookie-policy-link\" href=\"https://www.gilead.com/privacy-statements/cookie-statement\" aria-label=\"More information about your privacy, opens in a new tab\" rel=\"noopener\" target=\"_blank\">Cookie Policy.</a></div></div></div><div id=\"onetrust-button-group-parent\" class=\"ot-sdk-three ot-sdk-columns has-reject-all-button\"><div id=\"onetrust-button-group\"><button id=\"onetrust-pc-btn-handler\" aria-label=\"Cookies Settings, Opens the preference center dialog\">Cookies Settings</button> <button id=\"onetrust-reject-all-handler\">Reject All</button> <button id=\"onetrust-accept-btn-handler\">Allow All</button></div></div></div></div><!-- Close Button --><div id=\"onetrust-close-btn-container\"><button class=\"onetrust-close-btn-handler onetrust-close-btn-ui banner-close-button ot-close-icon\" style=\"background-image: url(&quot;https://cdn.cookielaw.org/logos/static/ot_close.svg&quot;);\" aria-label=\"Close\"></button></div><!-- Close Button END--></div></div><div id=\"onetrust-pc-sdk\" class=\"otPcTab ot-hide ot-fade-in\" lang=\"en\" aria-label=\"Preference center\" role=\"region\"><div role=\"dialog\" aria-modal=\"true\" style=\"height: 100%;\" aria-label=\"Privacy Preference Center\"><!-- pc header --><div class=\"ot-pc-header\" role=\"presentation\"><!-- Header logo --><div class=\"ot-pc-logo\" role=\"img\" aria-label=\"Company Logo\"><img alt=\"Company Logo\" src=\"https://cdn.cookielaw.org/logos/bf68afa0-3c8d-4d2e-9472-6b54f14f5822/d513e377-2af9-4a8a-b1d3-6d6d76674030/2b260913-9721-4f2a-897f-ca50399ed98a/Gilead_Logo_standard_RGB.png\"></div><div class=\"ot-title-cntr\"><h2 id=\"ot-pc-title\" aria-hidden=\"false\">Privacy Preference Center</h2><div class=\"ot-close-cntr\"><button id=\"close-pc-btn-handler\" class=\"ot-close-icon\" aria-label=\"Close preference center\" style=\"background-image: url(&quot;https://cdn.cookielaw.org/logos/static/ot_close.svg&quot;);\"></button></div></div></div><!-- content --><!-- Groups / Sub groups with cookies --><div id=\"ot-pc-content\" class=\"ot-pc-scrollbar ot-sdk-row\"><div class=\"ot-optout-signal ot-hide\"><div class=\"ot-optout-icon\"><svg xmlns=\"http://www.w3.org/2000/svg\" aria-hidden=\"true\"><path class=\"ot-floating-button__svg-fill\" d=\"M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z\" fill=\"#FFF\" fill-rule=\"evenodd\"></path></svg></div><span></span></div><div class=\"ot-sdk-container ot-grps-cntr ot-sdk-column\"><div class=\"ot-sdk-four ot-sdk-columns ot-tab-list\" aria-label=\"Cookie Categories\"><h2 id=\"ot-pc-title-mobile\" aria-hidden=\"true\">Privacy Preference Center</h2><ul class=\"ot-cat-grp\" role=\"tablist\" aria-orientation=\"vertical\"><li class=\"ot-abt-tab\" role=\"presentation\"><!-- About Privacy container --><div class=\"ot-active-menu category-menu-switch-handler\" role=\"tab\" tabindex=\"0\" aria-selected=\"true\" aria-controls=\"ot-tab-desc\"><h3 id=\"ot-pvcy-txt\">Your Privacy</h3></div></li><li class=\"ot-cat-item ot-always-active-group ot-vs-config\" role=\"presentation\" data-optanongroupid=\"BG439\"><div class=\"category-menu-switch-handler\" role=\"tab\" tabindex=\"-1\" aria-selected=\"false\" aria-controls=\"ot-desc-id-BG439\"><h3 id=\"ot-header-id-BG439\">Strictly Necessary Cookies</h3></div></li><li class=\"ot-cat-item ot-vs-config\" role=\"presentation\" data-optanongroupid=\"BG440\"><div class=\"category-menu-switch-handler\" role=\"tab\" tabindex=\"-1\" aria-selected=\"false\" aria-controls=\"ot-desc-id-BG440\"><h3 id=\"ot-header-id-BG440\">Performance Cookies</h3></div></li><li class=\"ot-cat-item ot-vs-config\" role=\"presentation\" data-optanongroupid=\"BG441\"><div class=\"category-menu-switch-handler\" role=\"tab\" tabindex=\"-1\" aria-selected=\"false\" aria-controls=\"ot-desc-id-BG441\"><h3 id=\"ot-header-id-BG441\"> Targeting &amp; Social Media Cookies</h3></div></li><li class=\"ot-cat-item ot-vs-config\" role=\"presentation\" data-optanongroupid=\"BG442\"><div class=\"category-menu-switch-handler\" role=\"tab\" tabindex=\"-1\" aria-selected=\"false\" aria-controls=\"ot-desc-id-BG442\"><h3 id=\"ot-header-id-BG442\">Functional Cookies</h3></div></li></ul></div><div class=\"ot-tab-desc ot-sdk-eight ot-sdk-columns\"><div class=\"ot-desc-cntr\" id=\"ot-tab-desc\" tabindex=\"0\" role=\"tabpanel\" aria-labelledby=\"ot-pvcy-hdr\"><h4 id=\"ot-pvcy-hdr\">Your Privacy</h4><p id=\"ot-pc-desc\" class=\"ot-grp-desc\">When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.)</p></div><div class=\"ot-desc-cntr ot-hide ot-always-active-group\" role=\"tabpanel\" tabindex=\"0\" id=\"ot-desc-id-BG439\"><div class=\"ot-grp-hdr1\"><h4 class=\"ot-cat-header\">Strictly Necessary Cookies</h4><div class=\"ot-tgl-cntr\"><div class=\"ot-always-active\">Always Active</div></div></div><p class=\"ot-grp-desc ot-category-desc\">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. You can set your browser to block or alert you about these cookies, however if you do so, some parts of the site will not work.</p></div><div class=\"ot-desc-cntr ot-hide\" role=\"tabpanel\" tabindex=\"0\" id=\"ot-desc-id-BG440\"><div class=\"ot-grp-hdr1\"><h4 class=\"ot-cat-header\">Performance Cookies</h4><div class=\"ot-tgl\"><input type=\"checkbox\" name=\"ot-group-id-BG440\" id=\"ot-group-id-BG440\" role=\"switch\" class=\"category-switch-handler\" data-optanongroupid=\"BG440\" checked=\"\" aria-labelledby=\"ot-header-id-BG440\"> <label class=\"ot-switch\" for=\"ot-group-id-BG440\"><span class=\"ot-switch-nob\"></span> <span class=\"ot-label-txt\">Performance Cookies</span></label> </div><div class=\"ot-tgl-cntr\"></div></div><p class=\"ot-grp-desc ot-category-desc\">These cookies allow us to count visits, collect analytics, and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. In certain countries prior to banner acceptance, performance cookies may be sent to your browser. You may clear these cookies in your browser settings so that we will not know when you have visited our site and will not be able to monitor its performance.</p></div><div class=\"ot-desc-cntr ot-hide\" role=\"tabpanel\" tabindex=\"0\" id=\"ot-desc-id-BG441\"><div class=\"ot-grp-hdr1\"><h4 class=\"ot-cat-header\"> Targeting &amp; Social Media Cookies</h4><div class=\"ot-tgl\"><input type=\"checkbox\" name=\"ot-group-id-BG441\" id=\"ot-group-id-BG441\" role=\"switch\" class=\"category-switch-handler\" data-optanongroupid=\"BG441\" checked=\"\" aria-labelledby=\"ot-header-id-BG441\"> <label class=\"ot-switch\" for=\"ot-group-id-BG441\"><span class=\"ot-switch-nob\"></span> <span class=\"ot-label-txt\"> Targeting &amp; Social Media Cookies</span></label> </div><div class=\"ot-tgl-cntr\"></div></div><p class=\"ot-grp-desc ot-category-desc\"><strong>Targeting Cookies</strong><br><br>These cookies allow us to count visits, collect analytics and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. In certain jurisdictions prior to banner acceptance, performance cookies may be sent to your browser. They can track your browser across other sites and build a profile of your interests. They may impact the content and messages you see on other websites you visit. You may clear these cookies in your browser settings so that we will not know when you have visited our site and will not be able to monitor its performance. \n<br><br><br>\n<strong>Social Media Cookies</strong><br><br>These cookies are set by social media services that we may have added to the site to enable you to share our content with your friends and social or professional networks. They can track your browser across other sites and build a profile of your interests. They may impact the content and messages you see on other websites you visit. </p></div><div class=\"ot-desc-cntr ot-hide\" role=\"tabpanel\" tabindex=\"0\" id=\"ot-desc-id-BG442\"><div class=\"ot-grp-hdr1\"><h4 class=\"ot-cat-header\">Functional Cookies</h4><div class=\"ot-tgl\"><input type=\"checkbox\" name=\"ot-group-id-BG442\" id=\"ot-group-id-BG442\" role=\"switch\" class=\"category-switch-handler\" data-optanongroupid=\"BG442\" checked=\"\" aria-labelledby=\"ot-header-id-BG442\"> <label class=\"ot-switch\" for=\"ot-group-id-BG442\"><span class=\"ot-switch-nob\"></span> <span class=\"ot-label-txt\">Functional Cookies</span></label> </div><div class=\"ot-tgl-cntr\"></div></div><p class=\"ot-grp-desc ot-category-desc\">These cookies enable the site to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.</p></div></div></div></div><!-- Vendors / Hosts --><section id=\"ot-pc-lst\" class=\"ot-hide ot-pc-scrollbar ot-enbl-chr\"><div class=\"ot-lst-cntr ot-pc-scrollbar\"><div id=\"ot-pc-hdr\"><div id=\"ot-lst-title\"><button class=\"ot-link-btn back-btn-handler\" aria-label=\"Back\"><svg id=\"ot-back-arw\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" x=\"0px\" y=\"0px\" viewBox=\"0 0 444.531 444.531\" xml:space=\"preserve\"><title>Back Button</title><g><path fill=\"#656565\" d=\"M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835\n                  l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425\n                  c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564\n                  s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978\n                  L213.13,222.409z\"></path></g></svg></button><h3>Cookie List</h3></div><div class=\"ot-lst-subhdr\"><div id=\"ot-search-cntr\"><p role=\"status\" class=\"ot-scrn-rdr\"></p><input id=\"vendor-search-handler\" type=\"text\" name=\"vendor-search-handler\" placeholder=\"Search\u2026\" aria-label=\"Cookie list search\"> <svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" x=\"0px\" y=\"0px\" viewBox=\"0 -30 110 110\" aria-hidden=\"true\"><path fill=\"#2e3644\" d=\"M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23\n              s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92\n              c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17\n              s-17-7.626-17-17S14.61,6,23.984,6z\"></path></svg></div><div id=\"ot-fltr-cntr\"><button id=\"filter-btn-handler\" aria-label=\"Filter Cookie List\" aria-haspopup=\"true\"><svg role=\"presentation\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" x=\"0px\" y=\"0px\" viewBox=\"0 0 402.577 402.577\" xml:space=\"preserve\"><title>Filter Button</title><g><path fill=\"#2c3643\" d=\"M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136\n                            c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083\n                            c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413\n                            C402.765,25.895,404.093,19.231,400.858,11.427z\"></path></g></svg></button></div></div></div><section id=\"ot-lst-cnt\" class=\"ot-pc-scrollbar\"><div class=\"ot-sdk-row\"><div class=\"ot-sdk-column\"><div id=\"ot-sel-blk\"><div class=\"ot-sel-all\"><div class=\"ot-sel-all-hdr\"><span class=\"ot-consent-hdr\">Consent</span> <span class=\"ot-li-hdr\">Leg.Interest</span></div><div class=\"ot-sel-all-chkbox\"><div class=\"ot-chkbox\" id=\"ot-selall-hostcntr\"><input id=\"select-all-hosts-groups-handler\" type=\"checkbox\"> <label for=\"select-all-hosts-groups-handler\"><span class=\"ot-label-txt\">checkbox label</span></label> <span class=\"ot-label-status\">label</span></div><div class=\"ot-chkbox\" id=\"ot-selall-vencntr\"><input id=\"select-all-vendor-groups-handler\" type=\"checkbox\"> <label for=\"select-all-vendor-groups-handler\"><span class=\"ot-label-txt\">checkbox label</span></label> <span class=\"ot-label-status\">label</span></div><div class=\"ot-chkbox\" id=\"ot-selall-licntr\"><input id=\"select-all-vendor-leg-handler\" type=\"checkbox\"> <label for=\"select-all-vendor-leg-handler\"><span class=\"ot-label-txt\">checkbox label</span></label> <span class=\"ot-label-status\">label</span></div></div></div></div></div></div></section></div><div id=\"ot-anchor\"></div><section id=\"ot-fltr-modal\"><div id=\"ot-fltr-cnt\"><div id=\"ot-filter-list-header\"></div><button id=\"clear-filters-handler\">Clear</button><div class=\"ot-fltr-scrlcnt ot-pc-scrollbar\"><ul class=\"ot-fltr-opts\"><li class=\"ot-fltr-opt\"><div class=\"ot-chkbox\"><input id=\"chkbox-id\" type=\"checkbox\" class=\"category-filter-handler\"> <label for=\"chkbox-id\"><span class=\"ot-label-txt\">checkbox label</span></label> <span class=\"ot-label-status\">label</span></div></li></ul><div class=\"ot-fltr-btns\"><button id=\"filter-apply-handler\">Apply</button> <button id=\"filter-cancel-handler\">Cancel</button></div></div></div></section></section><!-- Footer buttons and logo --><div class=\"ot-pc-footer ot-pc-scrollbar\"><div class=\"ot-btn-container\"><button class=\"save-preference-btn-handler onetrust-close-btn-handler\" ot-button-order=\"0\">Confirm My Choices</button><div class=\"ot-btn-subcntr\"><button class=\"ot-pc-refuse-all-handler\" ot-button-order=\"1\">Reject All</button> <button id=\"accept-recommended-btn-handler\" ot-button-order=\"2\">Allow All</button></div></div><div class=\"ot-pc-footer-logo\"><a href=\"https://www.onetrust.com/products/cookie-consent/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Powered by OneTrust Opens in a new Tab\"><img alt=\"Powered by Onetrust\" src=\"https://cdn.cookielaw.org/logos/static/powered_by_logo.svg\" title=\"Powered by OneTrust Opens in a new Tab\"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- Arrow SVG element --><!-- Accordion basic element --><span class=\"ot-scrn-rdr\" aria-atomic=\"true\" aria-live=\"polite\"></span><!-- Vendor Service container and item template --></div><iframe class=\"ot-text-resize\" sandbox=\"allow-same-origin\" title=\"onetrust-text-resize\" style=\"position: absolute; top: -50000px; width: 100em;\" aria-hidden=\"true\" data-gtm-yt-inspected-1003614_477=\"true\" data-gtm-yt-inspected-1003614_481=\"true\" data-gtm-yt-inspected-1003614_482=\"true\" data-gtm-yt-inspected-1003614_483=\"true\" data-gtm-yt-inspected-1003614_485=\"true\" data-gtm-yt-inspected-1003614_631=\"true\" data-gtm-yt-inspected-1003614_1178=\"true\" data-gtm-yt-inspected-1003614_748=\"true\" data-gtm-yt-inspected-1003614_1084=\"true\" data-gtm-yt-inspected-552=\"true\"></iframe></div><div id=\"ot-sdk-btn-floating\" class=\"ot-floating-button ot-hide\" data-title=\"Cookies Settings\"><div class=\"ot-floating-button__front custom-persistent-icon\"><button type=\"button\" class=\"ot-floating-button__open\" aria-label=\"Cookies Settings\"></button></div><div class=\"ot-floating-button__back custom-persistent-icon\"><button type=\"button\" class=\"ot-floating-button__close\" aria-label=\"Close Preferences\" aria-hidden=\"true\" style=\"display: none;\"><!--?xml version=\"1.0\" encoding=\"UTF-8\"?--> <svg role=\"presentation\" tabindex=\"-1\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http://www.w3.org/2000/svg\"><g id=\"Page-1\" stroke=\"none\" stroke-width=\"1\" fill=\"none\" fill-rule=\"evenodd\"><g id=\"Banner_02\" class=\"ot-floating-button__svg-fill\" transform=\"translate(-318.000000, -725.000000)\" fill=\"#292B2E\" fill-rule=\"nonzero\"><g id=\"Group-2\" transform=\"translate(305.000000, 712.000000)\"><g id=\"icon/16px/white/close\"><polygon id=\"Line1\" points=\"13.3333333 14.9176256 35.0823744 36.6666667 36.6666667 35.0823744 14.9176256 13.3333333\"></polygon><polygon id=\"Line2\" transform=\"translate(25.000000, 25.000000) scale(-1, 1) translate(-25.000000, -25.000000) \" points=\"13.3333333 14.9176256 35.0823744 36.6666667 36.6666667 35.0823744 14.9176256 13.3333333\"></polygon></g></g></g></g></svg></button></div></div></div></body></html>",
    "actions": [
        {
            "action": "scrollBottom",
            "elapsedTime": 5.01,
            "status": "success"
        },
        {
            "action": "waitForTimeout",
            "elapsedTime": 15.001,
            "status": "success"
        }
    ]
}